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With over 16 million women using opioids in the United States, neonatal abstinence 
syndrome (NAS) is increasing, and evidence suggests that NAS may be alleviated by 
breastfeeding. Yet, many women with opioid use disorder (OUD) experience stigma related to 
breastfeeding that potentially influences their decisions surrounding breastfeeding. No theoretical 
framework was identified that explained how perceived stigma influences breastfeeding 
decision-making in this population. Hence, the purpose of this study was to explore how women 
with OUD perceive breastfeeding, how stigma influences their breastfeeding decisions, and how 
support person perceptions influence breastfeeding among women with OUD. 
A grounded theory study was conducted with 10 women in treatment for OUD who were 
between 18 and 54 years of age and who breastfed a child in the last three years. Women were 
recruited from a drug rehabilitation therapy agency, a high-risk obstetrical office, and a major 
medical center. Each woman was asked to identify a breastfeeding support person. Data were 
generated from in-depth interviews of the women and their support persons, then coded in three 
iterative and progressive phases: initial, focused, and theoretical, leading to a theoretical model. 
Memos and field notes were written, and a dyad profile was developed to analyze data from the 
 
 
dyad perspective. Current professional organization guidelines on breastfeeding were reviewed 
to inform this study.  
The women interviewed for this study were White, with an average age of 30. Most had 
some college but were unemployed and had one to six pregnancies each. Symptom management 
or social and environmental factors led the women through a pain-prescription or street drug 
pathway before they hit rock bottom and began recovery. The overarching theme was 
Breastfeeding Decision-Making in an Addiction Trajectory. This was characterized by the 
Recovery-Relapse Cycle and Breastworks. Women had multiple Recovery-Relapse Cycle 
experiences, which involved seeking, initiating, and maintaining recovery and at times relapse, 
that influenced breastfeeding decisions. Breastworks describes the empowerment of women for 
maternal breastfeeding decisions with the goal of protecting the infant. Support persons were 
White with an average age of 39; all had some college and most worked full-time. Support 
persons expressed an uncertainty about breastfeeding with OUD related to the infant’s health and 
mother’s potential to relapse. Yet this uncertainty did not deter them from providing both 
physical and emotional support to these breastfeeding women.  
Uncertainty may be evident to women with OUD through good intentions of their support 
persons that are negatively perceived. Furthermore, such support person uncertainty and 
healthcare provider insensitivity may be perceived as stigma towards women with OUD, thus 
decreasing Breastworks effectiveness and risking newborn well-being. This study provides 
unique theoretical concepts that may be incorporated into the care of women with OUD, from 
preconception to postpartum, to support breastfeeding decision-making and infant well-being. 
Implications include development of a mobile breastfeeding education application, incorporation 
 
 
of breastfeeding guidelines into continuing education, involving successfully recovered women 
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CHAPTER 1: INTRODUCTION 
 
 Women with substance use disorder (SUD) are among the nation’s most vulnerable 
populations. Almost 16% of women, ages 18 and older, used illicit drugs in 2016 and this 
continues to trend upward exponentially (Center for Behavioral Health Statistics and Quality, 
2017). Many of these women are in the childbearing stage of life. Substance misuse during 
pregnancy increases risks of adverse maternal and infant outcomes. When a woman uses illicit 
drugs during pregnancy, especially opioids, the infant may go through withdrawal after birth, a 
condition known as neonatal abstinence syndrome (NAS). Symptoms of NAS include 
respiratory, gastrointestinal, and neurologic involvement that can be fatal (Pritham, 2013). 
Breastfeeding alleviates the severity of withdrawal symptoms in some cases because small 
amounts of the opioid are passed into the breastmilk and consumed by the infant (O’Connor, 
Collett, Alto, & O’Brien, 2013). Due to low bioavailability and weight-based dosing for infants, 
an even smaller amount of the opioid is absorbed into the infant’s system, thereby slowly 
weaning the infants off the opioid as they grow (O’Connor et al., 2013). This natural 
environmental weaning from exposure to opioids and other substances often saves the lives of 
newborns (Welle-Strand, Skurtveit, Jansson, Bakstad, Bjarke, & Ravndal, 2013). Hence, 
breastfeeding among opioid exposed infants addresses one of the American Academy of Nursing 
national nursing science priorities, social determinants of health (Eckardt et al., 2017).  
The Science Committee of the American Academy of Nursing identified the 2017 
nursing science priorities as precision science, big data and data analytics, determinants of 
health, and global health (Eckardt et al., 2017). Determinants of health were further categorized 
as social and economic environment, physical environment, health care behaviors, genetics, and 





healthcare disparities are minimized, healthcare costs are decreased, and long-term infant health 
outcomes are improved, thus influencing social, economic, and healthcare determinants of 
health. Furthermore, the bonding that occurs during breastfeeding improves a mother’s chances 
of abstaining from substance use (Pritham, 2013), thereby improving the infant’s environment 
and the mother’s health care behaviors. Ultimately, the infant is spared potential epigenetic 
changes that may occur from various negative exposure that are minimized by breastfeeding 
(Eckardt, 2017). Hence, breastfeeding by women with OUD (OUD) addresses several aspects of 
the determinants of health.  
Women with OUD are less likely to breastfeed than women in the general population, 
further affecting the newborn’s chance of survival (Bhutta et al., 2014; O’Connor et al., 2013). 
Despite current evidence-based practice guidelines, clinicians debate the benefits of 
breastfeeding among women who have an OUD. Clinician apprehension regarding breastfeeding 
in this population is due to potential consequences for infant health if mothers with OUD do not 
adhere to drug rehabilitation therapy (DRT) as intended (Wachman, Saia, Humphreys, Minear, 
Combs, & Philipp, 2016). 
Due to potential legal or social consequences, women with OUD may be afraid to seek 
help for their OUD. The National Survey on Drug Use and Health reported in 2013 that of the 23 
million people who needed treatment for OUD, only 2.5 million people actually received 
treatment (Substance Abuse and Mental Health Services Administration [SAMHSA], 2014). 
This study in eastern North Carolina (eNC) is timely since North Carolina ranks the second 
highest state with increasing death rates from opioid misuse in the nation (Botelho, 2018). Four 
North Carolinians die of drug overdose per day (North Carolina Attorney General Stein, 2018). 





hormonal influences, women may become addicted faster (National Institute on Drug Abuse 
[NIDA], 2018). All ethnic and racial groups are affected by OUD, but it affects women of lower 
socioeconomic status most (SAMHSA, 2018). A lower socioeconomic status is reflected in 
North Carolina’s overall poverty rate of 15.4% (United States Census Bureau, 2017), which is 
above the national 14.7% poverty rate (University of North Carolina School of Law, n. d.). In 
addition, some areas of eastern North Carolina have poverty levels as high as 32% (University of 
North Carolina School of Law, n. d.).  
Statistics indicate low participation in DRT because some individuals with OUD avoid 
healthcare for fear of stigmatization (Gopman, 2014; Stone, 2015). Likewise, stigma influences 
other decisions of women with OUD, including breastfeeding. Stigma, which is historically 
prevalent, currently crosses every stratum of society (Cambridge University Press, 2018; Oxford 
University Press, 2018). Goffman (1963) wrote, “the issue becomes not whether a person has 
experience with a stigma of his own, because he has, but rather how many varieties he has had 
his own experience with” (p. 129), suggesting that stigma may be imposed on an individual by 
society or by the individual themselves.  
Background of the Problem 
 
 The misuse of substances likely began in the Neolithic period with the development of 
Shamanism to enter altered states of consciousness through psychoactive substances (Inaba & 
Cohen, 2014). Evidence of stigma towards those with SUD was noted around fourth century 
A.D. in Rome when heavy drinkers would be left in public, tied together with a cord thread 
through their noses (Inaba & Cohen, 2014). Historically, new substances have been created 
globally for religious, medical, or recreational purposes (Inaba & Cohen, 2014). Some of these 





benefits. Social stigma surrounding each substance influenced the next drug use era. For 
example, President Richard Nixon initiated the first War on Drugs in the 1970s to reduce 
availability of illegal substances. Individuals created their own substances because the demand 
for drugs remained high. Such responses to societal stigma led to the current illegal drug trade 
(Inaba & Cohen, 2014), and more specifically the current opioid epidemic (Macy, 2018).  
Currently, most available illicit drugs are impure from the use of non-consumable 
substances added during mass production. Non-consumable substances are incorporated to meet 
the growing drug demand (Inaba & Cohen, 2014; Macy, 2018). High demand may be attributed 
to drug tolerance, which is the requirement of more of the drug over time (Inaba & Cohen, 
2014). Increased demand for drugs secondary to tolerance has likely contributed to the 400% 
increase in overdose deaths among women since 1999 (SAMHSA, 2015). Such an increase is 
problematic because the number of pregnant women with OUD is rising, endangering lives of 
both mothers and unborn infants with each drug use. The US government identified that opioid 
misuse was reaching rates like those of the Nixon administration era. To reduce misuse rates and 
mortality within this population, the government began DRT programs through legislation, such 
as the Drug Addiction Treatment Act of 2000, the Affordable Care Act of 2010 and the 
Comprehensive Addiction and Recovery Act of 2016. These DRT programs use methadone and 
buprenorphine to replace illegal substances, hold patients accountable with random drug screens, 
and incorporate behavioral therapy (Jansson et al., 2016; McQueen, Murphy-Oikonen, Gerlach, 
& Montelpare, 2011). In 2010, only 19 states had a treatment program for pregnant women, with 
only nine giving pregnant women priority for treatment (American College of Obstetricians and 
Gynecologists [ACOG], 2011). Despite efforts to improve maternal outcomes, perceived stigma 





example, as of 2010, 15 states considered OUD to be child abuse, whereas three states 
involuntarily committed individuals to mental health or DRT programs (ACOG, 2011). Women 
with OUD in these 15 states likely avoid treatment for fear of legal consequences. Furthermore, 
DRT programs only minimize harm to the infant, as infant withdrawal remains a risk in spite of 
DRT.  
Though DRT minimizes infant risks, NAS may still occur. Neonatal abstinence syndrome 
is the collection of symptoms experienced by infants during withdrawal (Pritham, 2013). Most 
often, NAS results from fetal exposure to opioids, both prescription or illicit. However, NAS also 
occurs from exposure to benzodiazepines or alcohol in utero (Pritham, Paul, & Hayes, 2012). 
Such exposures can cause neurologic, respiratory, and gastrointestinal symptoms of withdrawal 
(Wachman et al., 2016). For example, infants with NAS may have a disorganized sucking pattern 
and increased respiratory rate that contributes to the challenge of breastfeeding with OUD. 
Unlike adults, abrupt cessation of opioid exposure can be fatal to infants (Pritham, et al., 2012). 
Prompt identification and treatment of withdrawal is necessary to preserve the neonate’s life.  
Infants experiencing NAS are typically monitored for at least 72 hours. Approximately 
50% of infants with NAS will have symptoms severe enough to require pharmacological 
treatment. The most widely used medication is morphine. Pharmacological treatments are 
generally administered on a scheduled basis (Abdel-Latif, Oei, Craig, & Lui, 2013; Bagley, 
Wachman, Holland, & Brogly, 2014; Balain & Johnson, 2014; Busch, 2016; Jones et al., 2012). 
Titration of the dose is dependent on the severity of infant symptoms, which are scored using a 
measurement tool, such as the modified Finnegan Scoring tool, and the infant’s weight (Bagley 
et al., 2014). However, treatment for mild cases may include multiple nonpharmacological 





One of the nonpharmacological treatments for infants born to mothers with OUD 
discussed in the literature is breastfeeding. Benefits of breastfeeding overall include decreased 
risks of infection, obesity, asthma, and Sudden Infant Death Syndrome (SIDS) in infants (United 
States Department of Health & Human Services [USDHHS], 2011).  A mother’s risk for breast 
and ovarian cancers are decreased exponentially by breastfeeding, and postpartum depression is 
suppressed through bonding that typically occurs with breastfeeding (USDHHS, 2011). 
Additionally, breastfeeding has been linked to decreased length of stay for NAS infants (Pritham, 
2013; Wachman et al., 2016). Although less than one percent per kilogram of the mother’s body 
weight of the drug crosses into breastmilk (O’Connor et al., 2013), it is imperative that drug-
addicted mothers understand the consequences of abrupt weaning and reintroduction of 
breastfeeding or expressed milk. A major consequence of abrupt weaning and reintroduction of 
breastmilk is the potential for reinitiating infant withdrawal symptoms that could lead to death if 
not identified and treated promptly. Breastfeeding education and support is necessary for women 
with OUD who breastfeed their infants to prevent the potential for setbacks in infant withdrawal 
progress due to weaning-reintroduction cycles . These well-known benefits of breastfeeding led 
to the Surgeon General’s Call to Action (USDHHS, 2011). 
The Surgeon General’s report called for bolstered support from family members, the 
community, and clinicians to decrease disparities in breastfeeding (USDHHS, 2011). 
Breastfeeding rates among women with OUD are much lower than the general population 
(Reece-Stremtan, Marinelli, & Academy of Breastfeeding Medicine, 2015). This disparity in 
breastfeeding may be due to perceived stigma. Without breastfeeding, an infant’s recovery from 
NAS is compromised, length of stay is increased, and healthcare costs rise (Bhutta et al., 2014; 





Research on Influences of Perceived Stigma on Breastfeeding Decisions among Women 
with OUD 
 
Only two studies were found that linked stigma to breastfeeding among women with 
OUD. The first study provided evidence that breastfeeding women with OUD are socially 
stigmatized. Mehta, Forbes, and Kuppala (2013) emailed an anonymous survey about 
breastfeeding with OUD to 383 leaders of different neonatal intensive care units (NICUs) in the 
United States. More than 25% of 179 respondents acknowledged that they “do not advocate 
breastfeeding” (Mehta et al., 2013, p. 321-322) in women with OUD. Demirci, Bogen, and 
Klionsky (2015) reported women with OUD experience stigma from the community, including 
their own family members or significant others, about breastfeeding their infants due to the fear 
of infant drug exposure and potential negative health outcomes. Demirci et al. (2015) described 
self-imposed stigma from mothers regarding breastfeeding as feelings that their breast milk was 
tainted, that the infant would refuse to breastfeed, and negative self-talk. Examples of negative 
self-talk include comments such as “I don’t want her to be all high or nothing, you know, 
because I am on a high dose [of methadone]” or “…Because I definitely didn’t want my baby to 
get that. My stupid mistakes going over to them.” (Demirci et al., 2015, p. 205).  
Despite lack of evidence about perceived stigma among women with OUD who 
breastfeed, numerous studies discuss stigmatization of other vulnerable populations, such as 
LGBTQ and persons with HIV or AIDS (Earnshaw, Smith, Chadoir, Rivet Amico, & 
Copenhaver, 2013; Mukherjee, McKinney, & Darrow, 2018). There are also known racial 
disparities among those with OUD regarding who is more likely to use illegal substances, who 
will reach out for help, and who will complete treatment (Mennis & Stahler, 2016; SAMHSA, 





may be an indication of similar racial disparities and potential stigma among women with OUD 
who breastfeed.  
Since the U. S. Surgeon General’s call to action, three professional organizations have 
released position statements on breastfeeding with OUD. The American College of Obstetricians 
and Gynecologists (ACOG, 2015) endorse the view that women with current or past OUD 
should not be criminalized or excluded from breastfeeding without careful consideration of the 
individual situation and proper education. The Academy of Breastfeeding Medicine (ABM) 
endorses multiple criteria for supporting breastfeeding among women with OUD (Reece-
Stremtan et al., 2015). These criteria include compliance with prenatal care, active participation 
in a DRT program, a negative toxicology screening at delivery, and abstinence from illicit 
substances for at least 90 days (Reece-Stremtan et al., 2015). The American Academy of 
Pediatrics (AAP, 2012) endorses the opinion that OUD is not a contraindication to breastfeeding 
if the woman is in a treatment program and has negative HIV and toxicology screens.   
Statement of the Problem 
 
Stigma deters individuals with OUD from seeking treatment (Stone, 2015). The influence 
of perceived stigma on breastfeeding decision-making negatively impacts maternal and infant 
health outcomes. Therefore, stigma affects the national nursing science priority, determinants of 
health, by influencing health behaviors, such as breastfeeding (Eckardt, et al., 2017). In a recent 
pilot study with six women with SUD who had recent breastfeeding experience, the overarching 
theme was Breastworks, a phenomenon depicting the protective nature of breastfeeding (Cook & 
Larson, 2019). While debriefing with a colleague about the results of the study, a quick search of 
Civil War terms presented Breastworks, which was a military term used to describe chest-height 





interrelated categories: The Battle, The Lockdown, and The Best Shot. The Battle the vicious 
cycle of using drugs, getting clean, and relapsing that influenced the mother’s breastfeeding 
decisions. The Lockdown involved the social and legal consequences that must be overcome to 
bond with their infants. The Best Shot involved the corrective actions by the women and 
aspiration to a better lifestyle (Cook & Larson, 2019). The constant push-and-pull identified by 
the women is what led to questioning how perceived stigma influences breastfeeding decision-
making processes among women with OUD.  
Purpose of the Study 
 
 The purpose of this study was to understand how perceived stigma influences 
breastfeeding decision-making processes among women with OUD. Although a number of 
theory-based studies explored breastfeeding in the general population, none specifically 
addressed stigma among women with OUD (Edwards, Jepson, & McInnes, 2018; Guo, Wang, 
Liao, & Huang, 2016; Lau, Lock, & Tarrant, 2018; McGlothen & Cleveland, 2018; McGlothen, 
Cleveland & Gill, 2018; Pitonyak, Jessop, Pontiggia, & Crivelli-Kovach, 2016; Primo & 
Brandao, 2017; Ryan, Team, & Alexander, 2017). Theory is necessary for understanding 
breastfeeding decision-making among women with OUD so that health disparities can be 
addressed and eliminated. Hence, a grounded theory (GT) approach was used to develop a theory 
on this topic. Grounded theory serves to develop a new theory from data collection where none 
previously existed or inadequately described the phenomenon (Charmaz, 2014; Creswell & Poth, 
2018).   
Significance of the Study 
 
 Prior research has focused on (a) why breastfeeding is beneficial in NAS, (b) bonding 





In addition, most research regarding stigma was from the clinicians’ perspectives. Qualitative 
studies involving perceptions of stigma among women with OUD focused on general care 
provision rather than breastfeeding. Hence, the aim of this study was to understand how 
perceived stigma influences decisions to breastfeed among women with OUD. Findings from 
this study can help clinicians improve lactation support systems at the micro and macro level. 
Improvement in lactation support systems could enhance maternal self-efficacy, which could in 
turn improve maternal and infant health outcomes. In addition, the known benefits of 
breastfeeding for NAS further contribute to the significance of this study.  
Research Questions 
 
This study answers the following research questions: 
Research Question 1 How do women with OUD feel about breastfeeding based on their 
perception of stigma and does stigma influence breastfeeding decisions among women with 
OUD? 
Research Question 2 How do perceptions of support persons influence decisions to support 
breastfeeding among women with OUD?  
Research Questions 3 What lactation systems support is currently present at the local and 
national level in policies, protocols, and guidelines for breastfeeding among women with OUD? 
Operational Definitions 
 
Stigma- Negative thoughts, perceptions, or actions towards women with OUD. There are two 
types: societal and self-stigma (Demirci et al., 2015). Societal stigma is imposed from outside 
sources, while self-stigma are internal thoughts (Demirci et al., 2015). 
Breastfeeding- Any amount of ingested maternal breast milk regardless of route, (nasogastric, 





Opioid Use Disorder- A history of opioid use/misuse, whether licit or illicit. 
Assumptions 
 
 In grounded theory (GT), truth is constructed from the participants’ experiences and 
accounted for from the researcher’s experiences (Charmaz, 2014). Once trust is gained, it was 
assumed that participants with OUD would share their experiences regarding breastfeeding, 
stigma, and decision-making honestly and accurately. Based on ten years of the researcher’s 
clinical practice experience caring for women with OUD and their infants, an assumption was 
that some participants may have missed opportunities of fully understanding the benefits of 
breastfeeding, especially in the context of societal and self-stigma.  
Summary 
 
 An understanding of how stigma influences breastfeeding decision-making processes 
among women with OUD is foundational to improve maternal and infant health outcomes. These 
health outcomes are national and international health priorities. Both the mother and infant 
affected by OUD stand to gain additional benefits from breastfeeding than the general 
breastfeeding population, yet women with OUD are less likely to breastfeed. The review of 
literature revealed societal stigma towards this population yet referenced self-imposed stigma 
minimally by women with OUD. No studies were found that explained how stigma influenced 
such breastfeeding decisions. This study explored how perceived stigma influences decisions to 
breastfeed among these women. Results of this study may bridge the gap between women with 
OUD and their support persons to improve breastfeeding rates and infant health outcomes, as 
well as inform health care professionals and health care systems of opportunities to support 





 The following chapter discusses the existing literature about influences of perceived 
stigma on breastfeeding decision-making processes among women with OUD. Next, a discussion 
of the GT methodology on research among the population of interest and a manuscript of the 
data gathered from the women with OUD is presented. Finally, a second manuscript discusses 




CHAPTER 2: LITERATURE REVIEW 
 
 This chapter provides a description of the sensitizing concepts of breastfeeding and the 
current science about influences of perceived stigma on decisions to breastfeed among women 
with opioid use disorder (OUD). Sensitizing concepts are broad terms from researcher 
knowledge that guide research inquiry (Charmaz, 2014). The literature review is organized by 
the following concepts: (a) OUD, (b) neonatal abstinence syndrome (NAS), and (c) 
breastfeeding. Additionally, OUD and breastfeeding concepts are addressed in relation to 
societal and self-stigma.  
Background and Significance 
 
The incidence of NAS in the US increased 300% from 1999 to 2013 (Ko, Patrick, Tong, 
Patel, Lind, & Barfield, 2016). This marked increase is due to overuse and/or misuse of licit and 
illicit opioids over the previous 14 years (Bagley, Wachman, Holland, & Brogly, 2014). 
Substance use disorder is a complex disease that has numerous long-term effects on everyone 
involved, including those who use opioids. Unfortunately, women in the southern US region are 
more likely to be prescribed opioids but have less access to treatment for OUD (Ostrach & 
Leiner, 2018). Infants exposed to opioids in-utero experience withdrawal symptoms. 
Breastfeeding lessens such side effects of exposure to opioids through both skin-to-skin contact 
and a miniscule amount of the opioid transferred to infants through breastmilk (Welle-Strand, 
Skurtveit, Jansson, Bakstad, Bjarke, & Ravndal, 2013). Stigma about breastfeeding among 
women with OUD influences their decisions about breastfeeding (Demirci, Bogen, & Klionsky, 
2015). Stigma that results in decisions against breastfeeding in this population have major short- 





relapse for the mother and severe NAS symptoms or long-term behavioral issues for infants. 
However, it is unknown exactly how stigma influences such decisions about breastfeeding.  
At the systems level, such as in hospitals, women with OUD have found themselves 
stigmatized through attitudes of the hospital staff (Cleveland & Gill, 2013). Investigators of a 
study of 179 US nursing and physician leaders in neonatal intensive care units found that more 
than 25% did not advocate for breastfeeding among mothers with OUD (Mehta, Forbes, & 
Kuppala, 2013). Other investigators found that new mothers felt judged for their substance use, 
which made them “feel ugly” and deterred them from bonding with their newborns (Cleveland & 
Gill, 2013, p. 203). These studies provide evidence that women with OUD experience stigma of 
breastfeeding from family, community, and society due to their OUD. Stigma may prevent 
women from obtaining adequate treatment, especially those who have children living with them, 
potentially leading to future “chronic health and social problems for the next generation” (Feder, 
Mojtabai, Musci, & Letourneau, 2018, p. 32). This may already be evident since readmissions 
among NAS infants is nearly double that of infants among the general population, many of 
which are related to injuries, abuse, and neglect often seen in children of women with OUD not 
in treatment (Witt, Rudd, Bhatraju, Rivara, Hawes, & Weiss, 2018). Many cultural influences 
affect the social and environmental factors surrounding breastfeeding, such as religious beliefs 
and familial practices of infant feeding. Hence, this research addresses one of the American 
Academy of Nursing national nursing science priorities, the determinants of health (Eckardt et 
al., 2017). McGlothen and Cleveland (2018) describe the disparity in breastfeeding among 
women with OUD as a social injustice that needs to be corrected. To address such a critical topic 





(2018), this study was conducted to understand how perceived stigma influences breastfeeding 
decision-making among women with OUD. 
Opioid Use Disorder 
 
Historically a problem with licit or illicit drugs was labeled substance abuse. This label 
changed to substance use disorder in the 5th edition of the Diagnostic and Statistical Manual of 
Mental Health Disorders (DSM-5; American Psychiatric Association, 2013). The diagnosis also 
expanded to a tri-level severity scale (mild, moderate, severe). The Substance Abuse and Mental 
Health Services Administration (SAMHSA, 2015) reinforced this definition stating, “Substance 
use disorders [are from] the recurrent use of alcohol and/or drugs caus[ing] clinically and 
functionally significant impairment … based on evidence of impaired control, social impairment, 
risky use, and pharmacological criteria” (Substance use disorders, para. 1). Opioid use disorder is 
classified as a type of SUD.  
Many factors contribute to addictions such as OUD, including heredity, the environment, 
and compulsivity (Inaba & Cohen, 2014). Most of these factors influence dopamine levels or 
receptors in the brain. The DRD2 A1 allele gene is thought to be related to a lack of dopamine 
receptors in the brain, causing compulsive behaviors and the need for more of a substance to feel 
the desired satisfaction, which contributes to addictive behaviors (Inaba & Cohen, 2014). The 
CYP2D6 gene has been linked specifically to OUD (Inaba & Cohen, 2014). In contrast, the 
DRD4 gene has been found to prevent addiction (Inaba & Cohen, 2014). Environmental 
exposures, such as positive home environments versus abusive environments, alter the chemistry 
of the brain through epigenetic adaptations (Inaba & Cohen, 2014).  
According to Inaba and Cohen (2014), genetics and environment in combination 





dosage increase is required to reach a similar effect, resulting in overdose (Inaba & Cohen, 
2014). One example is the global opioid epidemic (World Health Organization, 2014). Opioid 
overdose deaths in the U.S. have increased in women 400% since 1999 (SAMHSA, 2015). To 
address the epidemic, drug replacement therapy (DRT) programs were established with 
methadone implemented as the gold standard treatment (McQueen, Murphy-Oikonen, Gerlach, 
& Montelpare, 2011). Buprenorphine, a more recent DRT treatment, has also been used in place 
of illicit substances, such as opioids, with close observation and comprehensive care during 
pregnancy to treat OUD (Jansson et al., 2016).  
Two additional concerns were identified in the literature. One concern was the need to 
increase the DRT dosage in the third trimester (Jones et al., 2012) or split the dose evenly over 
24-hours to prevent withdrawal symptoms, thus preventing drug-seeking behaviors (Jones et al., 
2008; McCarthy, Leamon, Willits, & Salo, 2015; Mittal, 2014). The CYP 450 enzyme, present 
during pregnancy, lowers DRT medication half-lives requiring divided doses of DRT medication 
(McCarthy, Leamon, Finnegan, & Fassbender, 2017).  The second concern was that many 
women wish to transition from methadone to buprenorphine during pregnancy because of side 
effects, inconvenience, or varying insurance coverage between these two medication options. 
The concern with this transition during pregnancy is the risk of maternal health from accidental 
overdose and infant health related to severe withdrawal. Johnson and Martin (2018) trialed this 
transition with 20 women under close inpatient observation over four days. Almost 40% of 
women were strictly on buprenorphine at delivery and 80% felt it was successful (Johnson & 
Martin, 2018). Despite efforts to improve maternal outcomes, the influences of OUD, as well as 
medications utilized in DRTs, do not prevent infant withdrawal, but rather decrease severity of 





Neonatal Abstinence Syndrome 
 
Neonatal Abstinence Syndrome (NAS) most often results from fetal exposure to opioids 
across the placental barrier, but may also occur with exposure to benzodiazepines, alcohol, or 
other prescription pain medications in utero (Inaba & Cohen, 2014; Pritham, Paul, & Hayes, 
2012). Such exposures likely cause neurologic, respiratory, and gastrointestinal withdrawal 
symptoms. Unlike adults, abrupt cessation of opioid exposure can be fatal to infants (Pritham, et 
al., 2012). Exposed infants required a minimum of 72 hours of observation, often in an 
intermediate nursery during the delivery hospitalization. During this observational period, nurses 
typically score infant symptom severity using one of the following tools: (a) Neonatal 
Abstinence Syndrome Score (NASS)/Finnegan Score, (b) Narcotic Withdrawal Score/Lipsitz 
score, (c) Neonatal Narcotic Withdrawal Index, (d) Neonatal Withdrawal Inventory, and (e) 
MOTHER NAS Scale (Bagley et al., 2014). Despite concerns about reliability and validity, the 
most widely used scoring tool in the US is the modified Finnegan scoring tool (Bagley et al., 
2014; McQueen et al., 2011). In contrast, some researchers suggest that clinicians only monitor 
feeding, sleeping, and weight gain to make decisions regarding treatment, rather than using the 
modified Finnegan scoring tool (Grossman et al., 2017).  
Exposed infants often underwent NAS to an extent that required pharmacological 
treatment. Although results varied between studies from 0% to 100%, most investigators noted at 
least 50% of infants with NAS needed medication (Abdel-Latif, Oei, Craig, & Lui, 2013; Balain 
& Johnson, 2014; Busch, 2016; Jones et al., 2012). Pharmacologic treatment historically 
involved paregoric (Klaman et al., 2017) and diluted tincture of opium; morphine is now the gold 
standard treatment (Bagley et al., 2014). Currently, the recommended treatment of morphine is 





Clews, Cooke, Lui, & Oei, 2006). However, a more recent evidence-based practice is to provide 
morphine on an as needed basis only (Grossman et al., 2017). Second-line treatment included 
clonidine and phenobarbital (Bagley et al., 2014). Although Bagley et al. (2014) suggested that 
buprenorphine was promising in the treatment of NAS, buprenorphine’s safety in infants requires 
further validation.  
Prior to and during pharmacological treatment, nonpharmacological interventions were 
reported to soothe NAS infants. Interventions included swaddling the infant, keeping stimulation 
at a low level, and sucking (Pritham, 2013). Several studies suggested that breastfeeding may 
decrease NAS severity (Bagley et al., 2014; Balain & Johnson, 2014; Crook & Brandon, 2017).  
Breastfeeding 
 
The literature operationalized breastfeeding in various degrees. Crook and Brandon 
(2017) defined breastfeeding as infants receiving greater than 50% of feedings by breast or 
expressed maternal milk into a bottle. In contrast, Abdel-Latif et al. (2006) described 
breastfeeding as less than or equal to two formula feedings on the fifth day. According to Abdel-
Latif and colleagues (2006), by the fifth day of life breast milk supply should be at full capacity. 
McQueen et al. (2011) defined breastfeeding as receiving breast milk via any route more than 
75% in a 24-hour period. Yet another definition of breastfeeding was any amount of breast milk 
received regardless of route of ingestion (O’Connor, Collett, Alto, & O’Brien, 2013). For the 
purposes of this study, breastfeeding is defined as the provision of any amount of maternal breast 
milk to her infant by directly putting the infant to breast or expression of breast milk via pump 
and given to the infant via bottle, nasogastric, or orogastric tubes for any duration.  
General Breastfeeding Benefits. Although the definition and operationalization of 





(Balain & Johnson, 2014; Busch, 2016; Crook & Brandon, 2017; Holmes, Schmidlin, & 
Kurzman, 2017; Kocherlakota, 2014). Benefits of breastfeeding for mothers include decreased 
risk of breast cancer and depression, improved weight loss, and increased parenting confidence 
(American Academy of Pediatricians [AAP], 2018). Infant benefits include improved immunity, 
decreased risk of obesity, decreased risk of childhood cancers, and time-specific situationally-
tailored nutrition (Crook & Brandon, 2017). Situationally-tailored nutrition means that 
breastfeeding infants receive exactly what they needed nutritionally at the exact time needed, 
rather than nutrition provided by formula that is based on average infant nutrition requirements. 
Benefits of Breastfeeding with OUD. Mother-infant dyads with OUD and NAS receive 
additional breastfeeding benefits. Breastfeeding among women with OUD promotes a stronger 
bond between the mother and infant compared to their non-breastfeeding peers (Busch, 2016). 
Breastfed infants experiencing NAS have an improved sense of comfort and security compared 
to infants not breastfed (Pritham, 2013). Breastfeeding also decreased the risk of Sudden Infant 
Death Syndrome, which is higher in NAS than the general population (Edwards & Brown, 
2016). A mother’s guilt from observing NAS in her infant was abated with breastfeeding 
(Demirci, Bogen, & Klionsky, 2015). Skin-to-skin contact and direct breastfeeding soothed 
infants with NAS (Pritham, 2013). Breast milk was found to contain only small amounts of 
methadone or buprenorphine that could be consumed by infants while breastfeeding, thus 
deeming breastfeeding safe for infants of mothers in DRT (Pritham, 2013). In some instances, 
breastfeeding alleviated the severity of NAS symptoms (Welle-Strand et al., 2013). In spite of 
evidence supporting the benefits of breastfeeding in women with OUD, these women were less 
likely to breastfeed than women in the general population, further limiting the newborn’s 





such as accuracy of family members’ knowledge of infant feeding practices and personal beliefs 
(Karmacharya, Cunningham, Choufani, & Kadiyala, 2017; Lok, Bai, & Tarrant, 2017), that 
affect social and environmental factors surrounding breastfeeding decisions. Therefore, 
breastfeeding in this population addresses one of the national nursing science priorities, the 
social determinants of health (Eckardt, et al., 2017).  
Disadvantages to Breastfeeding with OUD. Clinicians remain concerned that women in 
DRT programs may not adhere to the program, putting their infants at risk if they misuse drugs 
and breastfeed (Holmes, Schmidlin, & Kurzman, 2017; Pritham, 2013; Wachman, Saia, 
Humphreys, Minear, Combs, & Philipp, 2016). However, investigators found that women who 
are aware of the risks do not wish to harm their infant and will do what is necessary to protect 
them (McGlothen, Cleveland, & Gill, 2018). Some of the manifestations of NAS may influence 
breastfeeding, such as increased muscle tone that contributes to a disorganized suck and infant 
weight loss (Holmes, Schmidlin, & Kurzman, 2017). No other disadvantages to breastfeeding 
among women with OUD in a DRT program have been presented in the literature. Despite the 
controversial nature of breastfeeding with OUD, many organizations support breastfeeding in 
this population (Holmes, Schmidlin, & Kurzman, 2017). 
Stance of Professional Organizations on Breastfeeding among Women with OUD. 
There are position statements regarding breastfeeding among women with SUD and OUD, from 
organizations that have influenced the development of guidelines and policies at state, national, 
and international levels. In 2009, the World Health Organization (WHO) released a document on 
acceptable reasons to provide a breast milk substitute, which supported breastfeeding with OUD 
if caution was used. In 2011, the U.S. Surgeon General’s call to action on breastfeeding included 





disparities in breastfeeding (U.S. Department of Health and Human Services [USDHHS], 2011). 
The AAP (2012) supported the stance of the WHO and endorsed the opinion that OUD is not a 
contraindication to breastfeeding if the woman is in a treatment program and has negative HIV 
and toxicology screens. The American College of Obstetrics and Gynecology (ACOG, 2015) 
endorsed the view that women with current or past OUD should not be criminalized or excluded 
from breastfeeding without careful consideration of the individual situation and proper 
education. The Academy of Breastfeeding Medicine (ABM) endorses multiple criteria for 
supporting breastfeeding among women with OUD (Reece-Stremtan, Marinelli, & ABM, 2015). 
These criteria include compliance with prenatal care, active participation in a DRT program, a 
negative toxicology screening at delivery, and abstinence from illicit substances for at least 90 
days prior to delivery (Reece-Stremtan et al., 2015). The North Carolina Perinatal and Maternal 
Substance Abuse Initiative conveyed support for breastfeeding while on medication-assisted 
therapy for OUD, as well as when to transition medications during breastfeeding (North Carolina 
Pregnancy and Opioid Exposure Program [NCPOEP], 2018).  
Societal Stigma 
 
Opioid Use Disorder. Corrigan and Nieweglowski (2018) state that stigma of OUD is 
“legally and socially sanctioned” (p. 44) as compared to other medical conditions, such as mental 
illness. Society views OUD as a dichotomy: a disease or a moral decision (National Institute on 
Drug Abuse [NIDA], 2014; NIDA, 2016). Henderson and Dressler’s (2017) residual agreement 
analysis provided supportive evidence of this medical disease versus moral decision dichotomy 
with their study involving interviews of undergraduate college students about the causes of 
addiction. The dichotomy contributes to stigmatization of individuals with OUD (Henderson & 





daily individual interactions. Findings from two qualitative studies further support this 
dichotomous viewpoint. Cleveland and Gill (2013) found themes related to stigma among 
Hispanic mothers of infants with NAS. Stigmatization of women with SUD was evident as the 
mothers described their experiences with hospital staff who discouraged them from participating 
in their infant’s care, which made them feel less in control (Cleveland & Gill, 2013; Howard, 
2015). Cleveland and Bonugli (2014) conducted interviews with 15 Hispanic mothers of infants 
with NAS. The importance of trust between mothers and nurses was a unique finding that was 
evident in mothers’ fears of being reported to child protective services (Cleveland & Bonugli, 
2014). Hatcher, Mendoza, and Hansen (2018) also caution that to avoid inadvertently isolating 
the mothers, treatment options should be based on individual needs rather than preconceived 
notions.   
Further, professional organizations such as SAMHSA deem stigma of OUD as a barrier 
to reducing addiction in the US (Corrigan & Nieweglowski, 2018). Howard (2015) echoes this 
thought in her phenomenological study of 30 women with OUD. The overarching theme of the 
study was perception of self with a subtheme of external stigma (Howard, 2015). External stigma 
was presented as the punitive nature of actions or statements by others that hindered women’s 
desire to go to prenatal appointments or visit their infants in a prolonged hospital stay (Howard, 
2015).  Ostrach and Leiner (2018) also stated that stigma of OUD leads to ambivalence about 
adherence to treatment medications, which may cause relapse. Those who desire to attend a 
narcotics anonymous group may be rejected if they are in a DRT because such groups do not 
view medication assisted therapy as being completely clean, adding to their ambivalence and 





Breastfeeding. The breast is viewed by mainstream American society as a sexual object 
rather than for provision of infant and child nutrition (Newton-Francis & Young, 2015). This 
notion is supported by results of a study of online responses to a woman being forced to leave a 
retail store for breastfeeding in public via social media and a news source commentary section 
(Grant, 2016). While only 2% of over 1000 comments on social media were negative, 85% of the 
884 responses on the news source were negative (Grant, 2016). Negative comments stated 
support for the store making the woman leave. 
Self-stigma 
 
Opioid Use Disorder. Women with OUD often stigmatize themselves for becoming 
addicted to opioids (Howard, 2015). Corrigan and Kosyluk (2014) described a self-stigma model 
in which individuals become aware of the stigma, agree with it, apply the stigma to themselves, 
which negatively impacts their self-esteem and self-efficacy. This process contributes to a “why 
try” effect (Corrigan, Bink, Schmidt, Jones, & Rüsch, 2016, p. 16) effect, alluding to the thought 
that there is no reason to try because the individual feels they are not worthy or capable. Both 
Oexle et al. (2018) and Wang, Link, Corrigan, Davidson, and Flanagan (2018) found that self-
stigma among individuals with mental illness decreases self-efficacy, further supporting 
Corrigan and Kosyluk’s (2014) model.  
Breastfeeding. An online survey of breastfeeding mothers (n = 845) revealed that 15% of 
women felt guilty about their feeding choices, 38% felt stigmatized, and 55% felt that they had to 
defend their feeding choices (Komninou, Fallon, Halford, & Harrold, 2017). Guilt among 
women who decided to breastfeed stemmed from external influences related to breastfeeding in 
public, while guilt in women that supplemented their infants with formula was from internal 





Brouwer, Drummond, and Willis (2012) suggested that self-stigma related to breastfeeding is not 
unique to the United States. In fact, such self-stigma may stem from decisions to breastfeed or 
avoidance of breastfeeding regardless of location. This is indicated by a study of Norwegian 
women who felt as though they had broken a law when they weaned their babies from 
breastfeeding prior to the socially accepted timeframe of six months to one year (Hvatum & 
Glavin, 2016).  
Current Theoretical Perspectives 
 
Although several theory-based studies were found that explored breastfeeding in the 
general population (Edwards, Jepson, & McInnes, 2018; Guo, Wang, Liao, & Huang, 2016; Lau, 
Lock, & Tarrant, 2018; Pitonyak, Jessop, Pontiggia, & Crivelli-Kovach, 2016; Primo & Brandao, 
2017; Ryan, Team, & Alexander, 2017), none specifically addressed stigma among breastfeeding 
women with OUD. Breastfeeding decision-making, maternal self-efficacy, lactation education, 
and lactation support were important concepts from the literature that served as sensitizing 
concepts for this study. However, the dearth of research about breastfeeding decision-making in 
women with OUD supported the need for a grounded theory (GT) study of the topic (Charmaz, 
2014).  
Despite the vast amount of literature regarding stigma on SUD and breastfeeding 
separately, evidence of stigma related to breastfeeding and women with OUD was minimal. 
Several researchers discussed societal stigma in this population and offered potential rationales, 
but few were rigorously supported. Two investigators suggested that women with SUD who 
breastfeed were stigmatized (Mehta et al., 2013; Balain & Johnson, 2014). Mehta et al. (2013) 
emailed an anonymous survey to 383 nursing and physician leaders of various neonatal intensive 





“do not advocate breastfeeding” (Mehta et al., 2013, p. 321-322) in the population of women 
with SUD despite current evidence to support its safety. Balain and Johnson (2014) provided a 
literature review, discussing a survey of 30 medical and nursing staff regarding their attitudes 
towards breastfeeding with SUD. The researchers found 13% of clinicians felt breastfeeding 
should not be encouraged and 11% felt that breastfeeding was harmful to the infants (Balain & 
Johnson, 2014). Lack of support for breastfeeding among women with SUD was related to infant 
safety, but evidence was not presented to support this concern (Jansson et al., 2016; Pritham, 
2013; Wachman et al., 2016).  
One qualitative descriptive study about stigmatization of breastfeeding women with SUD 
was identified. Women with SUD participated in individual interviews or small focus groups and 
reported experiencing stigma from the community, which included immediate family or 
significant others, about breastfeeding their infants due to the fear of infant drug exposure 
(Demirci et al., 2015). Mehta et al. (2013) established that there is likely stigma from clinicians 
caring for this population. Hence, there remains a disconnect between best practice and actual 
practice regarding breastfeeding in this population. Compounding this is a mother’s own lack of 
confidence in her decision to breastfeed her infant. Women with OUD need support at the micro 
and macro level to maintain a drug-free lifestyle and in choosing to breastfeed.  
Numerous investigators have identified guilt associated with self-stigmatization regarding 
breastfeeding in women with OUD (Crook & Brandon, 2017; Jansson & Velez, 2015; Pritham, 
2013; Sutter, Leeman, & His, 2014). Jansson and Velez (2015) also suggested that maternal 
anxiety related to the infant’s health was indicative of self-stigmatization. Demirci et al. (2015) 
described self-stigma from mothers regarding breastfeeding, such as feeling that their breast milk 





suggested that low maternal self-efficacy in women with SUD contributed to early cessation of 
breastfeeding, if they decide to breastfeed at all (Busch, 2016; Jansson & Velez, 2015; Welle-
Strand et al., 2013). However, Crook and Brandon (2017) suggest one way to reduce societal and 
self-stigma would be to include family and clinicians in lactation education.  
Critical Evaluation of Existing Knowledge 
 
 Existing literature about how stigma influences decisions to breastfeed among women 
with OUD is minimal. Most of this literature is anecdotal from clinical practice or other non-
empirical evidence. The empirical evidence primarily focuses on the clinicians’ perspectives. 
Most of the studies were retrospective cohort studies, few were prospective studies. One 
qualitative study about experiences of pregnant and postpartum women on methadone and 
breastfeeding decision-making had several methodological flaws (Demirci et al., 2015). First, the 
researchers collected data in different ways, through interviews of antepartum women and focus 
groups of postpartum women but analyzed the data together. The two focus groups had two 
people in each group, despite recommendations that focus groups include at least three people 
(Krueger & Casey, 2015). The study is further limited by use of a single geographic location for 
recruitment and no variation in the sample (Demirci et al., 2015).  
Gaps in the Literature 
 
The benefits of breastfeeding among the general population are well known. However, a 
greater understanding of how breastfeeding mitigates NAS symptoms and improves infant 
outcomes is needed. Uncertainties related to breastfeeding among women with SUD, including 
those with OUD are (a) whether the amount of drug that transfers into breastmilk affects NAS, 
(b) whether skin-to-skin contact provides comfort, or (c) whether it is the act of breastfeeding 





methadone/buprenorphine dosage on NAS severity and the effects of varying degrees of 
aggressiveness in NAS treatment on hospital length of stay. Although stigma is known to affect 
women with OUD, little is understood regarding how stigma is perceived by pregnant or 
postpartum women with OUD and how that perception affects their decisions regarding 
breastfeeding their infants. Most of the existing literature surrounding women with OUD are 
retrospective chart reviews and systematic reviews that lack sufficient detail for replication. The 
few prospective studies available lacked rigor in research design, especially regarding 
methodology. No studies were found that used a conceptual model in addressing breastfeeding 
decisions among women with OUD. This literature synthesis provides evidence of the need for a 
well-developed qualitative study exploring women’s perceptions of how stigma influences 
breastfeeding decision-making among women with OUD. In addition to perceptions of women 
with OUD, perceptions of their support persons regarding how stigma influences breastfeeding 
decisions could inform future clinical practice. Enhancements in breastfeeding support, on both 
the micro and macro levels, regarding women with OUD can improve infant health outcomes.  
Summary 
 
 The purpose of this chapter was to present the existing literature about the influences of 
perceived stigma on decisions to breastfeed among women with OUD. It is well known that 
OUD contributes to NAS, and that breastfeeding may alleviate NAS symptoms. Yet, women 
with OUD are less likely to breastfeed than the general population. Stigma likely influences 
decisions to breastfeed among women with OUD, but how it does so is uncertain. The literature 
presented about influences of perceived stigma on breastfeeding decision-making among women 
with OUD lacks the perspectives of women with OUD. This study aimed to develop a theory that 





women with OUD. Future nursing and medical practice will benefit from knowledge gained 




CHAPTER 3: METHODOLOGY 
 
 The purpose of this study was to understand influences of perceived stigma on 
breastfeeding decision-making from the perspective of women with opioid use disorder (OUD). 
To understand these decisions and gain the women’s perspective, a grounded theory (GT) 
approach was used to elicit their perceptions of how they made decisions to breastfeed. A 
discussion of constructivist GT methods regarding (a) design, (b) sample, (c) data collection, and 
(d) data management and analysis is presented. 
Theoretical Framework: Grounded Theory 
 
This study used GT to explore influences of perceived stigma on breastfeeding decision-
making through individual semi-structured interviews of women with OUD and the support 
persons they identified. The research was guided by the constructivist paradigm (Charmaz, 
2014), in which exploration of this phenomenon led to an explanation of the breastfeeding 
decision-making process where description was previously nonexistent (Creswell & Poth, 2018). 
According to Charmaz (2011), constructivism is specifically used in GT “to advance 
understanding of how power, oppression, and inequities differentially affect individuals, groups, 
and categories of people” (p. 362). This statement was particularly fitting for exploring how 
women with OUD perceive the influences of stigma on their decisions to breastfeed (Cleveland 
& Bonugli, 2014; Cleveland & Gill, 2013; Gopman, 2014). Lincoln, Lynham, and Guba (2011) 
and Scotland (2012) wrote that constructivism is related to relativism. Relativism proposes that 
there are several truths or realities that can be constructed by individuals or groups based on 
contextual features. The methods of GT are inductive, following patterns of events or 
documented notable behaviors to determine a theory for those patterns. This study featured 





the voice of participants, researchers were closely engaged with participants and the data that 
originated from responses about their environment and daily life. Relativism and the emic-etic 
synergy between researcher and participant were necessary to ensure the research findings 
reflected the participants’ own understanding while acknowledging the personal experiences of 
the researcher (Lincoln et al., 2011). To accurately reflect the experiences of women with OUD, 
perception of stigma in the context of breastfeeding and the researcher’s personal experiences 
and background were explicitly stated so that findings were derived from the data rather than 
researcher beliefs and experiences, thus minimizing researcher bias.  
Entrée in the Study 
 
The researcher’s context (personal experience) was included in GT data collection and 
analysis. My clinical background includes ten years of experience in maternal-infant care and six 
years of experience as an International Board-Certified Lactation Consultant. I have experienced 
various disparate scenarios related to caring for infants who experience moderate to severe 
neonatal abstinence syndrome (NAS). I have been present when mothers were incarcerated and 
unable to remain with their infants. I have witnessed infants removed from the mother’s custody 
by Child Protective Services. In other instances, mothers with OUD have remained at the bedside 
actively caring for the infant but were discouraged from breastfeeding by clinicians or family 
members. I have listened as mothers expressed their confusion about breastfeeding with OUD 
and yet, other times as a mother with OUD breastfed her infant and bonded effectively. 
Researcher context informed participant data through memos and field notes, to construct 









In a pilot study of six women with substance use disorder (SUD), actively enrolled in a 
drug rehabilitation therapy (DRT) program, who had recently breastfed, I explored the influences 
of SUD on breastfeeding decisions. The overarching theme was Breastworks, which depicts the 
empowerment of women in their breastfeeding decision-making to protect their infants. There 
were three supporting categories: The Battle, The Lockdown, and The Best Shot. These three 
interrelated categories described the vicious cycle of recovery and relapse, The Battle, often 
leading to social and legal consequences for these women, The Lockdown. Breastworks was a 
way the women found to overcome this cycle and bond with their infants, aspiring to an 
improved lifestyle (Cook & Larson, 2019). The constant push-and-pull from the women’s voices 
led me to explore the influences of perceived stigma on breastfeeding decision-making among 
women with OUD for this study, given the current opioid epidemic.  
Protection of Human Subjects 
 
 Participants were protected in this study a variety of ways. First, I obtained letters of 
support from all study sites. Next, institutional review board (IRB) and agency ethics committee 
approvals were obtained (Appendix A). For IRB purposes, a waiver of signed informed consent 
was obtained for the participant (Appendix B). Women with OUD also identified and recruited a 
support person to participate in the study. The support persons were required to sign a written 
informed consent for IRB purposes (Appendix C).  
Protection of Privacy 
 
I conducted each one-on-one interview in a private location agreed upon with the index 
participant or support person. I audio-recorded and transcribed the interviews. Identifying 





electronic copies of the transcripts were saved on an encrypted, password protected computer in 
a locked office within the university. Once transcription was completed and verified by a faculty 
with expertise in qualitative research, the audio files were deleted. Hard copies of transcripts 
were kept in a locked cabinet in a locked office of the university. Participant demographic data 
was filed separately from the interview transcripts. All electronic and hard copies will be kept for 
at least three years. After that time, all data files will be destroyed.  




In the pilot study, recruitment of six participants occurred over 11 months from a single 
site. Additional protection of this vulnerable population and organizational challenges 
contributed to lengthy recruitment efforts. Hence, for the current study I recruited women from 
three locations: an outpatient DRT program, an obstetrical-gynecological (OBGYN) practice, 
and a major medical center. The outpatient DRT program offers treatment options for men and 
women with mental illness, SUD, and intellectual or developmental disabilities. Three of the 
branches of the DRT were approved by the agency ethics committee for recruitment sites in the 
pilot study by Cook and Larson (2019). These same three branches were also approved for this 
study. The OBGYN practice serves women of all ages within the reproductive and menopause 
years, specializing in high-risk pregnancies such as those among women with OUD. The major 
medical center serves women and children from 29 surrounding counties in eastern North 
Carolina (eNC) through its specialty hospital.   
Sampling Strategy 
 
 A purposeful sample of women with OUD who had recent breastfeeding experience were 





OUD, (2) involved in an outpatient methadone or buprenorphine DRT program in eNC, (3) 18 
years of age or older, (4) speak English, and (5) have breastfed her infant in the last three years. 
For the purposes of this study, breastfeeding was operationalized as directly latching the infant to 
the breast or providing expressed breastmilk via bottle or nasogastric tube. During recruitment 
efforts in a preliminary study of this population (Cook & Larson, 2019), women often mentioned 
they would be interested in participating if the time since breastfeeding was not as restrictive 
(greater than two years versus the less than two-year requirement). Though recall bias may be of 
concern, Gresham et al. (2015) reported that women recall child-specific perinatal outcomes 
from at least four years prior with 95% accuracy when compared to medical records. In the same 
study, Cook and Larson (2019) only included women between 18 and 44 years of age. However, 
as unintended pregnancies are a risk of OUD and age of first-time mothers increased 23% over 
35 years of age, it was determined that the inclusion of women 45 to 54 years old was reasonable 
(Mathews & Hamilton, 2016). Exclusion criteria were women younger than 18 and over 54 years 
of age, those who did not speak English, women who breastfed their child more than three years 
ago, and women with OUD obtaining inpatient treatment. 
Women were recruited via face-to-face individual or group presentations of the study 
purpose with invitational flyers provided at the recruitment presentation (Creswell & Poth, 
2018). Theoretical sampling was obtained from different age, parity, occupational and 
educational statuses (Creswell & Poth, 2018). Each index participant was encouraged to identify 
one support person. Identified support persons were defined as significant others, family 
members, friends, or other individuals the participant deemed supportive of their breastfeeding. 
Index participants either obtained the support person’s permission for the PI to contact them or 





directly to schedule an interview. Lack of a support person did not lead to exclusion from the 
study. To generate sufficient knowledge for GT, literature suggests 20 to 60 interviews are 
needed (Charmaz, 2014). This study had 17 total interviews. We attempted to achieve theoretical 
saturation with this number of interviews.   
The study sample was derived from women with OUD currently being served by an 
outpatient DRT program, a local high-risk OBGYN office, or a major medical center. Women on 
methadone are required to go to the treatment facility daily for their doses and must attend a 
therapeutic group session three times a week, lasting three hours per session. In contrast, women 
on buprenorphine received a weekly prescription and were required to attend a one-hour 
therapeutic group session twice monthly. Most of the women from the DRT programs selected 
for this study have children, but often lack support from family and friends. Hence, treatment 
requirements and family obligations often conflict with each other. In addition, some women 
have transportation challenges, which can be difficult for recruitment and research participation. 
Thus, giving participants reasonable options for interview locations was necessary. 
Compensation for participant efforts and contributions are suggested for adequate recruitment 
among vulnerable populations as well (Jessiman, 2013). Funding was obtained to provide 
educational sessions to key agency gatekeepers and a $20 gift card to participants and support 
persons for their time and contribution to this study. Gatekeeper educational sessions described 
the purpose of the study, eligibility criteria, and what assistance was needed from the agency 
staff. Key agency gatekeepers included nurses, social workers, doctors, and ancillary staff. Food 









 One to two in-depth semi-structured interviews were conducted separately in a private 
location with eligible women and their identified support person. Interview questions were 
developed from the principal investigator’s (PI) experience and from the extant literature 
(Appendices D & F). Faculty with expertise in qualitative methods further assisted in refining the 
interview questions to ensure appropriateness for GT methodology. Examples of questions for 
women were: (1) describe your thoughts about breastfeeding with OUD, (2) describe someone 
that assisted you to breastfeed, and (3) describe someone or something that made it more difficult 
to breastfeed. Examples of questions for support persons were: (1) describe your thoughts about 
breastfeeding with OUD, (2) give an example of how you have been helpful when it came to 
breastfeeding with OUD, and (3) give an example of a time that you felt you could have been 
more helpful when it came to breastfeeding with OUD.  Demographics were obtained for both 
women and support persons (Appendices E & G). The interviews were audio-recorded and 
transcribed by the PI. Throughout the interviews, detailed field notes were kept regarding 
observations of participant behaviors, interactions with participants, and personal thoughts. A 
local hospital breastfeeding policy and breastfeeding guidelines from the North Carolina Prenatal 
Opioid Exposure Project (NCPOEP, 2018) were reviewed. Both documents reflected supporting 
breastfeeding among this population while in treatment. The following organizational position 
statements were reviewed and found to be supportive of breastfeeding with this population while 
in treatment: American Academy of Pediatrics (AAP, 2012) Breastfeeding and the Use of 
Human Milk, Academy of Breastfeeding Medicine (ABM) Clinical Protocol #21: Guidelines for 
Breastfeeding and Substance Use or Substance Use Disorder, Revised 2015 (Reece-Stremtan, 





Committee Opinion Number 633: Alcohol Abuse and Other Substance Use Disorders: Ethical 
Issues in Obstetric and Gynecologic Practice, and World Health Organization (WHO, 2009) 
Acceptable Medical Reasons for Use of Breastmilk Substitutes.  
Data Management and Analysis 
 
 Data analysis was continuous from the first transcript, simultaneous with data collection, 
and iterative based on information gathered from incoming data (Giles, de Lacey, & Muir-
Cochrane, 2016). Incoming data that informed data analysis included the breastfeeding policies 
and guidelines reviewed, as well as support person interviews. Index person interviews were 
transcribed using Microsoft Word and then uploaded to NVivo, v12 for data management (QSR 
International, 2018). Data analysis was conducted through coding and constant comparison 
(Giles et al., 2016). Coding occurred in three stages, progressing from concrete codes to 
theoretical codes (Table 1). First, initial coding was completed to find meaning among fragments 
of the transcripts and identify processes (Charmaz, 2014; Creswell & Poth, 2018). Initial coding 
was line-by-line in a quick, spontaneous manner assigning action words as codes (Charmaz, 
2014). The codes of each interview were compared to codes of the other interviews for 
similarities between them. Next, focused coding was done to conceptualize the phenomenon by 
regrouping codes based on patterns between them and across transcriptions (Charmaz, 2014). 
However, initial and focused coding were not linear, they were often concurrent or iterative 
based on the findings (Giles et al., 2016). Finally, theoretical coding identified relationships 
among the focused codes, reconnecting the fragments to develop a theory (Charmaz, 2014). 
Throughout the analysis, constant comparison was performed using memos to record the 
researcher’s thoughts about codes, patterns, and relationships (Giles et al., 2016). The use of 





abstraction necessary for theory development (Charmaz, 2014). Memos and field notes were 
analyzed iteratively along with the transcripts as this was helpful for conceptual development 





Grounded Theory Coding Matrix Example 
Exemplar Initial Code Focused Code Theoretical Code 
Like I literally just went back to [intensive 
program] last week, week before last, 
Thanksgiving week. And that was my decision 
because I tested positive for alcohol, and they 
said either ‘I’m cutting your medication down 
or off and you can stay in the one, once a week 
program or you can go back to [intensive 
program] and stay on your meds’. I’m like, 
‘okay, I’ll go back to [intensive program], 
‘cause I need my medicine’. So umm, its helped 
a lot, that’s for sure. (Kathryn, 31 years old) 
Increasing Treatment 
Intensity 








Evaluative Criteria for Qualitative Research Trustworthiness 
 
 To develop trustworthiness and rigor of this qualitative study, the evaluative criteria of 
credibility, transferability, dependability, and confirmability are addressed. 
Credibility. Credibility, or the ability to trust the researcher’s work (Polit & Beck, 2017), 
was maintained in multiple ways. First, theoretical sampling was pursued so that the developed 
theory would include varying perspectives relevant to the concepts of breastfeeding and OUD 
(Polit & Beck, 2017). For instance, women with varying numbers of children and amount of 
breastfeeding experience provide different perspectives. Second, participant confidentiality was 
ensured for the duration of the study by securely storing de-identified data on an encrypted 
password protected university drive and in a locked cabinet of a locked office at the university. 
Participant contact information was stored in a separate, yet similarly protected location. Third, 
privacy was maintained during interviews by ensuring they were conducted in a private space 
which prevented the conversation from being overheard. Memos, field notes, and reflexive 
journals only included pseudonyms to further protect participant privacy. Fourth, interviews 
were transcribed by the researcher verbatim to stay true to the participant’s voice. Accuracy of 
transcripts were verified by a dissertation committee member. Fifth, following Charmaz’s (2014) 
guidance, data was coded in three progressive stages: initial, focused, and theoretical, to develop 
a theory explaining the influences of perceived stigma on breastfeeding decision-making among 
women with OUD. Sixth, the researcher had meetings with the dissertation chair weekly to 
discuss the progress of the study, allowing for peer-review, debriefing, and reflexivity that 
ensured representation of participants’ voices versus researcher bias. Seventh, data were 





organization guidelines on breastfeeding. Finally, the researcher had prolonged contact with the 
agencies and population with persistent observations. 
Transferability. Transferability was addressed in three ways. First, the context of the 
researcher’s background and experiences was explicitly identified so that readers could make 
their own judgements about applicability in their area of interest (Charmaz, 2014; Polit & Beck, 
2017). Second, thorough description of the recruitment sites was presented when reporting 
findings so that readers could identify similarities and differences between locations for potential 
study replication. Third, exemplars of the participant responses with thick description were 
presented so that comparisons of similar populations in different geographic regions could be 
identified by the reader (Polit & Beck, 2017).  
Dependability. Dependability was maintained through various documents such as 
detailed field notes, memos, and notes from meetings with the dissertation committee. 
Additionally, member checking was conducted during interviews with probe questions for 
clarification and a codebook was kept that the expert qualitative researcher reviewed throughout 
data analysis. The development of visual models and thematic analysis also supported the 
dependability of the study (Polit & Beck, 2017). A thorough reporting of the methods used to 
conduct the study allowed others to potentially replicate the research design.  
Confirmability. Confirmability was supported by three methods. First, explicitly stating 
the researcher’s orientation in relation to the study allowed for reflexivity to ensure that the 
findings presented were representative of the participant’s experiences and the data collected 
rather than the researcher (Polit & Beck, 2017). Second, keeping detailed memos, an audit trail, 
and other thorough records provided proof of the process and further removed researcher bias. 





interviewing individuals of the target population from several branches of the outpatient DRT 
program, the major medical center, and the high risk OBGYN practice (Creswell & Poth, 2018; 
Polit & Beck, 2017). Additionally, breastfeeding policies were examined along with the 
transcripts and memos to inform data collection and analysis. By using the above strategies, 
trustworthiness was addressed throughout this GT study in all phases of the study trajectory.  
Potential Limitations and Alternative Approaches 
 
 Although this study was rigorous, there were limitations. The use of one geographical 
location, a purposive sample, and the homogeneity of the sample limits the transferability of the 
findings to larger populations. Only one geographical location was utilized for this study, as it 
was meant to explore the phenomenon and develop a theory that could be used for further 
research and interventions with this population. The sample was very specific; therefore, women 
with OUD who have not enrolled in a treatment program may have been missed. Although a 
proportional number of African American women were present at recruitment sites and invited to 
participate, many said that their children were older than the inclusion criteria allowed, or they 
were not able to participate due to other obligations of daily life. Hence, the sample is of all 
White women. While a quantitative study utilizing a questionnaire might have been an 
alternative option, the design would lack the richness of the data obtained in this GT study. 
Nursing science would continue to have a gap in knowledge of why women with OUD make the 






CHAPTER 4: BREASTFEEDING DECISION-MAKING IN AN ADDICTION 




Objective: To explore how maternal perceptions of stigma influence breastfeeding decisions. 
Methods: A Grounded Theory study was conducted with women with opioid use disorder 
(OUD) using one to two in-depth interviews. Women between 18 and 54 years of age, who 
breastfed a child in the last three years were recruited from a drug rehabilitation therapy agency, 
high-risk obstetrical office, and a major medical center. Each woman was asked to identify a 
support person to interview. Data were coded in three iterative and progressive phases: initial, 
focused, and theoretical, leading to a theoretical model. 
Results: Ten women and six support persons participated. The major findings were that these 
women faced Breastfeeding Decision-Making in an Addiction Trajectory, characterized by the 
Recovery-Relapse Cycle and Breastworks. Women had multiple Recovery-Relapse Cycle 
experiences, which involved seeking, initiating, and maintaining recovery and at times falling 
into relapse, which influenced breastfeeding decisions. Breastworks describes the empowerment 
of women for maternal breastfeeding decisions with the goal of protecting the infant.  
Conclusion: This study provides unique theoretical concepts that may be incorporated into the 
care of women with OUD, from preconception to postpartum, to support breastfeeding decision-
making and infant well-being. Implications include development of a mobile application for 
breastfeeding education, incorporation of breastfeeding guidelines into continuing provider 
education, and involving successfully recovered women as community health workers. 






Women with substance use disorder are among the nation’s most vulnerable populations. 
Almost 16% of women, ages 18 and older, used illicit drugs in 2016; this percentage continues to 
trend upward exponentially (Center for Behavioral Health Statistics and Quality, 2017). This 
means that every 15 minutes a baby is born to an opioid dependent woman (National Institute of 
Drug Abuse, 2019). Neonatal abstinence syndrome (NAS) is a group of symptoms that infants 
may experience from prenatal exposure to opioids (Kocherlakota, 2014). These symptoms 
include mild to severe gastrointestinal, nervous system, and respiratory symptoms that can cause 
extreme discomfort. Gastrointestinal symptoms may include poor feeding despite hunger, severe 
abdominal pain, vomiting, and diarrhea (Pritham, 2013). Nervous system involvement can lead 
to tremors, irritability, convulsions, and seizures (McGlothen, Cleveland, & Gill, 2018). 
Respiratory symptoms may include tachypnea, making infant feeding unsafe because of 
respiratory distress (Kocherlakota, 2014). Unlike adult withdrawals, if NAS is not treated it can 
be fatal (Kocherlakota, 2014). Neonatal withdrawal is typically monitored using the Finnegan 
scoring tool, which defines mild as a score of less than four, moderate as a score of five to eight, 
and severe symptoms as greater than eight (Kocherlakota, 2014).  
While first line treatment of severe NAS is morphine, mild to moderate symptoms are 
treated with nonpharmacological interventions. Such interventions include swaddling, providing 
a pacifier, and decreasing environmental stimulation. Breastfeeding is another effective 
intervention. Extensive research shows breastfeeding mitigates infant withdrawal symptoms, 
thus allowing infants to quickly and more easily adjust to extrauterine life (Schiff et al., 2018). 




leaving their infants at a disadvantage (McGlothen & Cleveland, 2018). The reason for the 
disparity among women with OUD is unclear. 
It is known that women with OUD experience stigma related to their substance use and 
such stigma prevents them from seeking treatment (Stone, 2015). However, literature about how 
stigma influences breastfeeding decisions among women with OUD is minimal. Most of this 
literature is retrospective. The few prospective studies focus on the clinicians’ perspectives. One 
qualitative study about how the experiences of pregnant and postpartum women on methadone 
influence breastfeeding decisions had several methodological flaws (Demirci, Bogen, & 
Klionsky, 2015). Sensitizing concepts were lactation support, lactation education, and self-
efficacy, which came from breastfeeding literature in the general population. Sensitizing 
concepts are broad terms from researcher knowledge that guide research inquiry (Charmaz, 
2014). Despite such research, there is a paucity of theoretically-based research about how stigma 
influences breastfeeding decisions among women with OUD. Hence, the purpose of this study 
was to explore maternal perceptions of breastfeeding and how stigma influenced breastfeeding in 
women with OUD. 
Methods 
 
A Grounded Theory approach was used to meet the purpose of this study. Grounded 
Theory strives to develop an understanding of a phenomenon that has not previously been 
described (Charmaz, 2006). Data is coded in three progressive, yet iterative phases, from 
concrete to more abstract so that a theory or explanation can be developed. First, participants’ 
voices are foregrounded as data is broken into smaller, more manageable parts during initial 
coding. Second, initial codes are iteratively compared between data sources for similarities that 




identify themes of the topic being explored. The themes, categories, and subcategories are then 
organized into a theoretical framework that can be used to compare similar populations and for 
guidance in their care (Charmaz, 2006; Giles, de Lacey, & Muir- Cochrane, 2016).  
Prior to initiation of the study, agency and university IRB approvals were obtained 
(Appendix A). A waiver of signed informed consent (Appendix B) was acquired to protect the 
women with OUD because a consent form would be “the only record linking the subject and the 
research … [meaning] the principal risk would be potential harm resulting from a breach of 
confidentiality.” (Electronic Code of Federal Records, 2018). In contrast, support persons were 
required to sign an informed consent to participate (Appendix C). 
Researcher Context 
 
 In grounded theory, the researcher’s context influences data collection and analysis. The 
first author and principal investigator (KC) is a current doctoral candidate and registered nurse of 
10 years, with experience caring for women with OUD and their infants in a major medical 
center and is an International-Board Certified Lactation Consultant. Over the years, KC has 
observed the challenges that many women face during this period in their lives. Hence, the 
researcher’s experiences contribute to the rationale for the study design and methodology.  
Setting and Sample 
 
This study took place in eastern North Carolina (eNC). Participants were recruited from 
three separate agencies. First, women were recruited from two sites of an outpatient drug 
rehabilitation therapy (DRT) agency that serves adults with OUD. Second, recruitment occurred 
in a high-risk obstetrical office where pregnant women are monitored for prenatal care. Third, 
women were recruited from a major medical center where they gave birth and received further 




OUD who were between 18 and 54 years of age and enrolled in a DRT agency in eNC. Inclusion 
criteria were that women spoke English and breastfed their child within the last 3 years. The 
women were asked to identify one support person who could be interviewed, but women were 
not excluded if no support person was available. The only inclusion criteria for the support 
person was that the woman identified the individual as supportive of her breastfeeding efforts. 
Exclusion criteria were women younger than 18 and over 54 years of age, those who did not 
speak English, women who breastfed their children more than three years ago, and women with 
OUD obtaining inpatient treatment. 
Data Collection 
 
Women were recruited through individual and face-to-face group sessions where they 
were introduced to the purpose of the study and invited to participate. During these sessions, KC 
clarified with potential participants that breastfeeding included any amount of time 
breastfeeding. An invitational flyer (Appendices I & J) was distributed that asked the women to 
contact the nurse investigator via phone to schedule an interview. Women who contacted the 
investigator were reminded of the inclusion criteria before scheduling the interview to affirm 
their eligibility and the voluntary nature of the research.  
Interviews of Women with OUD and Support Persons. Prior to beginning the 
interview, consent was obtained from each participant (Appendices B & C) and demographics 
were obtained (Appendices E & G). Private semi-structured interviews were conducted by the 
principal investigator (KC) with the participants, both the women and support persons, at a 
location of their choice for their comfort. Interview questions included their personal thoughts of 
breastfeeding with OUD, perceptions of experiences with breastfeeding, and perceptions of 




Breastfeeding Guidelines from Professional Organizations. Data from current 
breastfeeding policies further informed data collection and analysis. Position statements 
regarding breastfeeding among women with OUD have influenced the development of 
guidelines and policies at national and state levels. In 2009, the World Health Organization 
(WHO) released a document on acceptable reasons to provide a breast milk substitute. This 
document supported breastfeeding with OUD if caution was used. In 2011, the U.S. Surgeon 
General’s call to action on breastfeeding included a need for greater support from family 
members, the community, and clinicians to decrease disparities in breastfeeding (U.S. 
Department of Health and Human Services [USDHHS], 2011). The AAP (2012) supported the 
stance of the WHO and endorsed the opinion that OUD is not a contraindication to breastfeeding 
if the woman is in a treatment program and has negative HIV and toxicology screens. The 
American College of Obstetrics and Gynecology (ACOG, 2015) endorsed the view that women 
with current or past OUD should not be criminalized or excluded from breastfeeding without 
careful consideration of the individual situation and proper education. The Academy of 
Breastfeeding Medicine (ABM) endorses multiple criteria for supporting breastfeeding among 
women with OUD (Reece-Stremtan, Marinelli, & ABM, 2015). These criteria include 
compliance with prenatal care, active participation in a DRT program, a negative toxicology 
screening at delivery, and abstinence from illicit substances for at least 90 days prior to delivery 
(Reece-Stremtan et al., 2015). The North Carolina Perinatal and Maternal Substance Abuse 
Initiative supported breastfeeding while on medication-assisted therapy for OUD, as well as 
when to transition medications during breastfeeding (North Carolina Pregnancy and Opioid 





Data Management and Analysis 
 
Audio-recordings were used to transcribe the interviews. Pseudonyms were assigned to 
all participants to protect their identity. KC then reviewed the transcripts in comparison to the 
audio recordings for accuracy. Transcripts were saved on a password protected and encrypted 
drive approved by the university IRB and managed using NVivo, v12 (QSR International, 2018). 
The second author (KLL) verified transcripts for clarity and accuracy. Field notes were written 
immediately after each interview with participants, and breastfeeding policies regarding OUD 
were reviewed from several professional organizations.  
Transcripts were read numerous times by both investigators for iterative and constant 
comparison coding according to Charmaz’s (2006) guidance (Table 2). Initial coding of 
transcripts began as each interview was transcribed and reviewed. This was done line-by-line to 
identify the unique participant experiences. The initial codes were then compared between the 
transcripts, leading to recoding of data as appropriate. Focused codes were more conceptual and 
were informed by the investigator’s knowledge of the population through experience caring for 
women with OUD. Focused codes led to categories necessary for theoretical coding. Theoretical 
coding allowed the researcher to identify important relationships in the data, thereby developing 
a theory. Memos were written throughout analysis to help the investigator process all the 






Example of Grounded Theory Coding: Raw Data to Theoretical Code 



























Ten women in treatment for OUD and six support persons participated in the study 
(Table 3). Although both White and African American women were recruited, only White 
women agreed to participate. Some African American women had children who were older than 
the three-year eligibility requirement, others did not breastfeed, and others did not want to 
participate in the research. Out of almost 200 women invited, half were from the DRT agency, 
75 were from the major medical center, and 25 were from the high-risk obstetrical office. Seven 
participants were recruited from the major medical center, two from the DRT agency, and one 
from the high-risk obstetrical office. One woman participated in a second interview for 
clarification of responses from her first interview. Prior to interviews, 10 to 20 minutes were 
spent building rapport through general conversation about the health of their babies. There was a 




producing 218 pages of double-spaced transcripts, 17 pages of field notes, and 21 pages of 
memos.  
Table 3. 
Demographic Characteristics of Women with OUD and Support Persons (N = 16) 
 Characteristic Mean Range n (%) 
Women with OUD  Age (years) 29.7 25-36 10 (100) 
 Race/Ethnicity 





 Education Level 
   Some HS 
   HS/GED 
   Some College 








 Occupational Status 
   Unemployed 
   Full-Time 




   1 
   2 
   3 
   4 
   5 
   6 
   
1 (10) 
2 (20) 




Support Persons  Age (years) 38.7 29-57 6 (100) 
 Race/Ethnicity 
   Caucasian 
   
6 (100) 
 Education Level 
   Some College 
   
6 (100) 
 Occupational Status 
   Unemployed 
   Full-Time 
   
2 (33) 
4 (67) 
The overarching theme in this study was Breastfeeding Decision-Making in an Addiction 
Trajectory, which was identified in the two major sub-themes Recovery-Relapse Cycle and 




environmental factors, pain-prescription pathway, street drug pathway, and hitting rock bottom. 
Some women entered the addiction trajectory in adolescence, but most entered in their twenties.  
Women entered the addiction trajectory either through a pain symptom management 
experience or by way of experiencing social and environmental risk factors. Eight women 
reported initiating their addiction trajectory beginning with symptom management. These 
women recounted medical concerns, such as a tooth extraction or back pain, that required 
prescription medications for pain. At times opioids were prescribed in combination with other 
potentially addictive medications, such as benzodiazepines. Two of the women from the pain-
prescription pathway went directly into recovery. However, six of the women described moving 
from the pain-prescription pathway to the street drug pathway early in their trajectories through 
influences from social and environmental risk factors that they encountered over time. 
In contrast, four women began their addiction trajectory through social and/or 
environmental risk factors, such as family instability, living in a risk-prone neighborhood, or 
access to medication, which led them to the street drug pathway. Family instability was 
characterized by parental divorce, relocations, personal breakups or divorce, intimate partner 
violence, loss of custody, death of parents, and stillbirth. Living in a risk-prone neighborhood 
was characterized by outside influences such as neighbors, peers, and friends who pressured the 
women into using opioids. Access to medication was characterized by the ability to steal others’ 
medications or the inability to access needed prescription medications. Women who either 
started in the street drug pathway, or went to this pathway later, described the experience of 
“hitting rock bottom”. Hitting rock bottom was defined as using stronger, more dangerous street 
drugs like heroin, cocaine, or methamphetamines, as well as becoming involved in the criminal 




Genetics can contribute to an addiction trajectory. One participant whose addiction was 
initiated through the pain-prescription pathway and later went to the street drug pathway, was 
told by a psychiatrist that she had an “addictive personality”: 
… I’ve just been told by, I guess, my psychiatrist and stuff that I have an addictive 
personality. Like, just umm, either all or nothing. Like doing too much or nothing at all. I 
mean I have addictions to food, like it’s just not drugs or alcohol necessarily. It can be 
sex, it can be food, it can be gambling, it can be, you know, anything (Suzy, 36-year-old 
mother of four). 
Genetic predisposition to addiction is associated with dopamine regulation. The DRD2A1 
allele gene causes decreased dopamine levels that contribute to the compulsive behaviors 
identified in those addicted, while the CYP2D6 gene is specifically linked to OUD and overdose 
risk (Inaba & Cohen, 2014). Though the opioid epidemic has a 20-year history, the 
neurobiological science behind its occurrence is in the early stages. According to Agarwal, 
Udoji, and Trescot (2017), about 10% of White people have a detrimental allele that is associated 
with OUD, though the prevalence varies among races and ethnicities. Such genetic 
predispositions likely contributed to hitting rock bottom, which led to the Recovery-Relapse 
Cycle.   
Recovery-Relapse Cycle 
 
The Recovery-Relapse Cycle was characterized by three categories, seeking, initiating, 
and maintaining recovery, and episodic relapse. One woman described the moment she realized 
that she was addicted after being peer-pressured into using pills by her boyfriend whom she 




… I never knew what withdrawals were. I didn’t know that there was even such a thing. 
And then, I remember in the morning I woke up and sweat, ya know, I was just sweating. 
And he was like, ‘yeah, you better take some’n, you’re gonna be sick today.’ And I was 
like, ‘Oh God, what have I done to myself?’ (Ginger, 25-year-old, mother of two). 
This participant is referring to being “dopesick” (Macy, 2018), the physical illness that 
people experience during withdrawal. One support person described being dopesick as “the flu 
times ten” (Adam, 28-year-old, Hannah’s fiancé). Symptoms experienced by adults are similar to 
those of NAS, but they are not fatal.  
Seeking. Seeking recovery was identified by some women as feigning suicide to get into 
treatment. One participant who had been prescribed pain medication after being severely beaten 
by her ex-husband and later gang raped then turned to street drugs, described her experience 
seeking recovery in the following exemplar: 
… I went to the hospital. Which, I was suicidal, but I wasn’t gonna hurt myself. But I told 
‘em I was going to. And umm, I had just been gang raped prior. That was actually what 
kind of led up to, like all of, everything. And they had psychiatrists, and everything come 
in. They told me they could tell I wanted help and that they were gonna make sure I got it 
(Tara, 31-year-old, mother of one). 
Another participant who attempted to initiate recovery on several occasions spoke of her 
challenges while seeking recovery during one of her attempts: 
… I went to jail one day, for actu-, okay I went to go into detox and the guy that was with 
me was sitting in the parking lot sniffing pills while I was in there trying to check in. So, 




too that I was gonna sneak into the detox so I wouldn’t feel as bad, ya know. Just stupid 
mess! But anyways, got arrested (Ginger, 25-year-old). 
Ginger was sneaking pills into detox to avoid being dopesick, even though she really 
wanted to be free of all substances. Yet another participant who was prescribed narcotics for pain 
related to endometriosis reported seeking treatment when her doctor stopped prescribing her 
medicine: 
And then the doctor stopped prescribing and by that time umm I was pretty dependent. 
Umm, and so, instead of having to go and look elsewhere for, ya know, medicine, I ended 
up going to treatment … (Ashton, 28-year-old mother of two). 
Seeking recovery eventually led to initiation of recovery for these women.  
Initiating. Initiating recovery was described as difficult for many reasons, but well worth 
it in the end. Some women were pressured into continuing opioid use by significant others even 
after reaching out for help. Others spoke of fearing the potential of becoming dopesick with 
detoxification. Finally, a few women were referred by a physician, as in the case of this woman 
who realized that she was addicted and needed help during her first visit at the DRT clinic for 
other reasons:  
…my doctor actually referred me to a facility just to take over my other medication that I 
was being prescribed. And when I found out that it was at like a treatment facility, I 
ended up telling ‘em about the sub, substance abuse and got help instead of refilling my 
medicine (Ashton, 28-year-old). 
One woman who previously described her unwavering search for help in recovering, 




… I get a phone call from [inpatient facility] personally to me saying, umm ‘We just let 
them know that we’ve opened a bed up for you.’ And they said ‘we could hear it in your 
voice that you were ready’ so. And, now I am here (Tara, 31-year-old). 
Another woman who started on pain pills for a tooth extraction described her experience 
of initiating recovery, stating, “... in that time, you end up doing a lot of soul searching and umm, 
I felt like I kind of found myself” (Sally, 30-year-old). Another woman also spoke of her 
experience initiating treatment stating, “… I did a 180 when I got on Subutex, and it’s worked 
for me a lot better than Suboxone did” (Ginger, 25-year-old). Once recovery was initiated, 
maintaining recovery was a daily challenge for these women.  
Maintaining. Maintaining recovery was described as continual and arduous. One 
participant outlined maintaining her recovery in this exemplar: 
… well it started out, when I first began going it was an intensive, every day, group 
sessions. I had to go every day of the week and they gave me my medicine there. Umm, 
once you pass drug tests and you go to your groups like you’re supposed to daily, and 
things like that, you can build up enough where you can get, uh, take homes. Like, you 
start out with just one. You take one dose home and you have to come get the rest there, 
but now I can take a whole weeks’ worth medicine home with me. And umm, I do two 
groups a month and one one-on-one session with my therapist. But umm, that’s as much 
as you can get it a weeks’ worth of the medicine at a time. … But umm, someone just 





This woman was proud of her ability to maintain sobriety and being given a weeks’ 
worth of medication, eliminating the daily visits to the DRT center for medication 
administration. Another woman who started taking unprescribed pain pills after the stillbirth of 
her son to find comfort spoke matter-of-factly about recovery maintenance stating: 
So, I followed it. Done everything I was supposed to do. Umm, I’ve had, not had a 
relapse. Don’t plan on having a relapse. Don’t have an-, the cravings anymore. 
Completely despise it (Sarah, 28-year-old, mother of four). 
Like Sally and Sarah, many other women reflected a sense of pride for maintaining 
recovery. In addition to pride, most women reported fearing withdrawal. One participant who 
struggled to wean from prescription pain medication explained that such fear of being dopesick 
was her initial reason for maintaining recovery in this exemplar, “… you have like withdrawals if 
you don’t have the medication. … And I have not experienced that with the Suboxone” 
(Christina, 34-year-old, mother of three). One woman explained the importance of maintaining 
recovery: 
The stability of the medication and the, uh yeah, the medicine that you’re prescribed. And 
also, being that you’re in treatment too, knowing that they’re, ya know, constantly drug 
testing you and all that stuff, it’s like, it encourages you to stay clean and just, stay on the 
medication managed by the doctor (Ashton, 28-year-old). 
 Relapse. Relapse is part of the Recovery-Relapse Cycle that is a constant threat in the 
lives of these women. One participant described a highly unstable family situation leading to her 




Got into treatment this go ‘round and I’ve been there since December 2015. Like I 
literally just went back to [intensive program] last week, week before last, Thanksgiving 
week. And that was my decision because I tested positive for alcohol, and they said either 
‘I’m cutting your medication down or off and you can stay in the one, once a week 
program or you can go back to [intensive program] and stay on your meds’. I’m like, 
‘okay, I’ll go back to [intensive program], ‘cause I need my medicine’. So umm, its 
helped a lot, that’s for sure (Kathryn, 31-year-old, mother of two). 
Identifying the need to stay in treatment and alter the intensity of treatment is critical to 
successful recovery. One participant described the commitment needed for successful recovery 
and prevention of relapse through her account of attempting recovery on several occasions: 
So, wow, it was a long road. Me and him, we tried to do treatment here or there, but I 
wasn’t serious about it. Ya know, and every time I would go to treatment and come 
home, and he would come home, he wanted to go right back to it. And so, I had to leave 
him. And umm, we ended up splitting up. … I was buying [Suboxone] off the street. And 
did strictly suboxone and I had smoked some weed here and there for a good while. For 
about two years then I started with cocaine. And then that was another journey to get 
clean from that, but umm, ever since I went to jail that day I never touched another pill 
and it’s been strictly suboxone or Subutex since then (Ginger, 25-year-old). 
All aspects of the recovery-relapse cycle influenced personal choices and decisions of 






While debriefing with a colleague whose brother-in-law is in the military about the 
results of the pilot study (Cook & Larson, 2019), a quick search of Civil War terms was 
suggested. The search presented Breastworks, a military term used to describe chest-height man-
made walls used for protection against enemy fire. I felt that Breastworks was well represented 
in the pilot study throughout the subthemes: The Battle, The Lockdown, and The Best Shot. This 
concept of Breastworks informed the current study (Cook & Larson, 2019) regarding 
breastfeeding decisions in women with OUD. Breastworks was further identified in this study 
when women described the power it took to defend their decision regarding breastfeeding while 
in recovery. Power was gained through Knowing and Learning, but also through their critically 
conscious evaluation of their role in the current circumstances and the resources necessary to 
change their infant outcomes. This knowledge gave them power to identify societal and self-
stigma influencing their decisions, which empowered them to take action to prevent negative 
outcomes (Rappaport, 1981). Empowerment to breastfeed was characterized by Knowing and 
Learning, Good Intentions, and Health Care Provider Sensitivity. Breastworks along with these 
concepts influenced the newborn’s well-being.   
Knowing and Learning. Breastworks was characterized by “Knowing and Learning”, 
which was how the women knew about breastfeeding benefits with OUD.  One woman spoke 
positively of her breastfeeding experiences with her three previous children, despite 
comorbidities like gastroschisis and tongue-tie. She also provided her plan to breastfeed her 
current infant at least two years: 
It’s been a good experience. And, I mean, I’ve done really well with it. It’s something 




breastfed her I think maybe three to six months. Then, my 12-year-old I breastfed him 
about a year. My six-year-old I breastfed him two years. … my daughter had 
gastroschisis and they just-, encouraged me to try it and because it was the healthiest 
option for her, I guess, in her like healing or whatever. So, I just tried it and it worked for 
me so, and I enjoyed it. … it wasn’t a question with my other children. It was just, I knew 
I was going to breastfeed (Suzy, 36-year-old). 
A few had unsuccessfully attempted to breastfeed a previous child and wanted to be 
successful with their current child, as in Hannah’s case who began her trajectory through peer 
pressure from neighbors: “With [first daughter], it was different with her. I didn’t last very long. 
But with her [second daughter], it’s been going pretty good.” (Hannah, 26-year-old, mother of 
two).  
 Good Intentions. Breastworks was also characterized by “Good Intentions” as women 
described the comments to them by family members, friends, and healthcare providers who were 
looking out for both the mother’s and the infant’s well-being. We further analyzed Good 
Intentions as wither positively or negatively perceived by the women. Positively perceived Good 
Intentions included instances such as lactation consultants trying to help a novice breastfeeding 
mother, the nutritionist for the Women, Infant, and Children (WIC) program who provided a 
breast pump, and family members continually asking about breastfeeding decisions. One 
participant who was experiencing breastfeeding for the first time stated: 
Just with the lactation specialists here, and people here at the hospital have helped me 
because I’m really new to it all. ... they supplied a hospital pump for me and the nurses 
and everybody have just all been really helpful in trying to encourage me and ...kinda 




In contrast, some good intentions were negatively perceived due to the amount of stress 
they caused. The same participant felt that too much help stressed her and her infant out, which 
prevented a successful breastfeeding session: 
I found that if there was a lot of people present in the moment, trying to kinda hands-on 
help, it just kinda stressed me out and it stressed my baby out. Umm, we just, we needed 
that time just me and her (Sally, 30-year-old). 
Though these perceptions were by the same participant, others expressed similar 
experiences. Another participant gave an example of her mother questioning why she would 
want to breastfeed: 
[My mom] may not want me to breastfeed because [daughter] will be getting Subutex 
still, ‘cause she did say yesterday, she said, ‘see, in my mind, you would want her to go 
ahead and get off of it while she’s there versus giving her little bits at a time. Ya know, 
when is she ever gonna get off of it?’ (Ginger, 25-year-old). 
Such positively and negatively perceived good intentions played a vital role in whether 
these women felt empowered in their decisions to breastfeed.  
Health Care Provider Sensitivity. Breastworks was characterized by fluctuating levels 
of Health Care Provider Sensitivity, identified through actions and statements from those caring 
for the mother or infant. Health Care Provider Sensitivity was described by one participant in 
regards to care during her most recent stay at the major medical center: 
… the pediatrician, they’ve recommended here as well, like, ‘yes please, we want you to 
continue to breastfeed.’ Ya know, even though we’ve had the major weight loss, they 




the formula as well. Ya know, not take over with formula, she breastfeeds and then after 
feeding THEN do the formula. (Marie, 28-year-old, mother of five). 
In contrast, several women described health care provider insensitivity when actions or 
statements were not necessarily perceived to be in the interest of the mother-infant dyad. A lack 
of Health Care Provider Sensitivity was perceived by women and their support persons as stigma 
against breastfeeding with OUD. Such insensitivity often placed more stress on the mother, who 
was already concerned about her infant’s well-being. One participant reported a scenario where 
the nurse questioned her adherence to treatment in a vague way: 
... she kinda asked me if my methadone was prescribed, and kinda [hinted] around that 
that was why the baby was losing weight, but she never came out directly and said that 
(Sally, 30-year-old). 
Another mother stated that her social worker suggested she stop breastfeeding without 
providing a rationale: “Yeah, my social worker wanted me to stop breastfeeding altogether, but I 
told her no, I couldn’t do that” (Hannah, 26-year-old). Yet another woman reported the staff 
being judgmental about her behavior when a medication error caused adverse side effects: 
… So, I had to kick out like, literally, every damn nurse because, just of how they were 
treating me. But then they called social services on us because I was falling asleep, while 
I was breastfeeding and because he was extra fussy. Once, my husband had been telling 
‘em ‘give him a paci, give him a paci, give him a paci’, they wouldn’t, well I mean they 
did finally, and he was cool. But they took their time, just like they took their time with 





One woman remarked how a comment by a physician made her decide to give up 
breastfeeding. Her newborn was losing weight and rather than considering a mutually beneficial 
solution, the physician gave her this ultimatum: 
… the doctor at that time told me I had one of two choices. Either I can continue to try to 
breastfeed and I go home and he [the newborn] stays at the hospital OR I switch to 
formula and he can start gaining weight and get healthy and then we can both go home. 
So, I wound up giving up breastfeeding right then and there and switched over to formula 
(Marie, 28-year-old). 
This participant described another incident of stigma related to her breastfeeding. Staff at 
one WIC office was perceived as judgmental during her request for a breast pump for use after 
delivery of a late-preterm infant: 
… the WIC office back home was telling me that I couldn’t get a breast pump because 
I’d have to be going back to work full-time and it would have to be, ya know, 40 hours 
plus a week, ya know immediately pretty much. And I’m sitting here going, well I 
couldn’t [go back to work] ‘til after eight weeks anyway (Marie, 28-year-old). 
Another participant perceived a lack of hospital staff willingness to assist her in learning 
to breastfeed her son, despite this being her first child: 
I felt like, almost in a way, that I was given. Like when it came time for that part 








The goal of Breastworks was newborn well-being, which involved monitoring the 
infant’s condition and protecting the infant from negative influences. Monitoring the infant’s 
condition was done through a collaborative effort between the mother, family, and health care 
providers. Protecting the infant from negative influences was also a collaborative effort, with the 
mother remaining in treatment and breastfeeding while the staff treated the infant for severe NAS 
and comorbidities, such as gastroschisis and lip or tongue-tie. An infant’s medical condition was 
dependent on his or her tolerance of withdrawal from prenatal exposure. Other conditions may 
have contributed to NAS scoring, such as gastroschisis and lip or tongue tie, which can alter 
irritability due to pain or hunger but are required to be scored with the tool most often used 
(Bagley, Wachman, Holland, & Brogly, 2014).  
Monitoring. Mothers are often very involved in their infant’s NAS scoring as they can 
provide insight about their sleeping and eating patterns between assessment times. One 
participant shared her knowledge of the infant monitoring process with her statement, “You 
know they’ve got to monitor them at least three days and, ya know, there’s certain things they 
look for…” (Marie, 28-year-old). While Tara did not share what questions the staff asked her 
about her son’s NAS symptoms, she expressed knowledge of monitoring NAS infants: 
[The nurses said,] ‘We don’t have nurseries no more unless there’s like some’n dramatic 
going on.’ And a lot of times now they’re using ‘em for babies that are coming off of 
narcotics (Tara, 31-year-old).  
Results from NAS monitoring influenced decisions about NAS treatment, which 




Protection. Protection encompasses the balance between emotional and physical needs 
of the infant. Bonding is an emotional need of infants, suggesting the need for maternal 
proximity and provision of care. However, the physical needs of the infant are dependent on the 
social and environmental factors involved regarding the dyad. Treatment of physical needs often 
centered around the severity of NAS symptoms observed. A few participants mentioned not 
giving their infants “morphine” and the use of resources, such as nipple shields or breast pumps, 
to prevent weight loss. The following exemplar describes treatment of infants and how 
breastfeeding can be integrated into the treatment regimen: 
… when I breastfed them it helped with their withdrawals or whatever … So, I mean, 
none of them had to be put on morphine or anything like that when they were born. … 
and I know that, like its common sense that they’re gonna get some of it through the 
breastmilk so, it was just, I knew that would help him calm, you know what I am saying, 
it would help him calm-, and do the transition easier (Suzy, 36-year-old). 
One woman shared resources that she had used to maintain low NAS scores and decrease 
the amount of weight loss expected for her infant: 
… we’re using the [nipple] shield… and then the next thing is pumping. I’ve been 
pumping every time afterwards. … at least trying to get her to feed and then if she 
doesn’t really feed from me, I’m pumping it so then I can put that in the bottle for her so 
that at least she’s getting it that way, if not from me (Marie, 28-year-old). 
Protection included breastfeeding, which successfully mitigated NAS, to promote the 







 This Grounded Theory study achieved the aims of exploring maternal perceptions of 
breastfeeding and how stigma influenced breastfeeding with a high-risk group of women in a 
state that is at the epicenter of the opioid crisis. The findings provide unique theoretical concepts 
that may be incorporated into the care of women with OUD to support breastfeeding decision-
making and infant well-being. This study provided the perspectives of a small sample of White 
women in a single geographic location, whose perspectives are critical to understanding 
breastfeeding decision-making in an addiction trajectory. This homogenous sample may be due 
to African Americans experiencing more stigma and having less trust in the research community 
from historical events. 
This study supports findings of existing literature, though current research is minimal and 
atheoretical on this topic. Additionally, this study confirms that women with OUD may perceive 
stigma about breastfeeding from healthcare providers that may not be as sensitive, as well as 
friends and family members with good intentions, as suggested by Demirci et al. (2015). 
Furthermore, this study supports the findings of McGlothen, Cleveland, and Gill (2018) 
regarding mothers with OUD desire to do what is best to protect their infants. This study further 
conceptualizes a theoretical framework in the Breastfeeding Decision-Making in an Addiction 
Trajectory Model.  
Most women started their addiction trajectories trying to manage pain, then progressed to 
street drugs to avoid being dopesick when they no longer had access to pain pills. Dopesick is 
characterized by several symptoms, but these participants described profuse sweating, nausea, 
vomiting, and severe pain. Previous partners often contributed to women’s relapse, while current 




partners pressured them into using pain pills illicitly and had them easily accessible, as in the 
case of one couple with a “pharmacy in the house”. Remaining in such environments promotes 
relapse and prevents recovery. Most women explained that they had to remove themselves from 
such partners to be successful in recovery.  
Addiction coupled with stigma made women reluctant to breastfeed. However, through 
various forms of knowing and learning, these women came to the realization that breastfeeding 
was the healthiest choice for their infants’ well-being. Women with OUD who had a greater 
knowledge of breastfeeding benefits for opioid-exposed infants were able to critically consider 
their infants’ potential outcomes and their role in protecting the infant, thus empowering them to 
confidently defend their decisions. Those who lacked such knowledge and confidence to defend 
their decision, were disempowered by insensitive comments from healthcare providers and good 
intentions from family and friends that were negatively perceived. The interaction of the 
woman’s knowledge, good intentions from family and friends, and experience of healthcare 
provider sensitivity all influenced the level of Breastworks evident in their situations.  
Women with greater Breastworks, or breastfeeding empowerment, continued breastfeeding 
despite perceptions of stigma. Continued breastfeeding contributed to the fulfillment of 
emotional and physical needs of infants, improved their NAS scores, and promoted bonding of 
the maternal-infant dyad. Thus, Breastworks is the fortress that protects Newborn Well-Being.  
This study offers several implications for research and practice. First, to advance the 
science we should consider the development of a mobile application to reach the highest-risk 
women and support persons about the benefits of breastfeeding for women with OUD at varying 
times throughout their addiction trajectory. There should be no uncertainty about the benefits of 




their decision to breastfeed at the last minute. Some said that they were not aware of the benefits 
of breastfeeding until they were delivering their infants. A few were not ready to hear the 
benefits when they were initially provided to them but later listened to staff and made their 
decision. Others initially had no intention of breastfeeding until the infant was delivered. One 
support person indicated that provision of breastfeeding education through smartphones and/or 
the internet would be a valuable resource. Mobile applications have been effectively used to 
provide information, at the individual’s convenience, for several other high-risk populations, 
such as those with alcoholism or suicidal tendencies (Han & Lee, 2018). Second, women who 
have been successful in recovery could become community health workers or lay health advisors 
in the community, functioning as a liaison between women with OUD and traditional healthcare 
providers, thus fostering trust. The implementation of community health workers has been 
studied and found to decrease healthcare provider distrust and fear of stigma in people who inject 
drugs (Morgan, Lee, & Sebar, 2015). Community health workers may be the missing link to 
successful care of women with OUD, especially for those who are pregnant or postpartum. 
Hodgins, Lang, Malseptic, Melby, and Connolly (2019) discuss a program implementation for 
integrated care of women with OUD that includes community health workers whose primary role 
is to build relationships with the women and enroll them in needed services available through the 
program. Third, a practice implication is to assure current breastfeeding guidelines are part of 
healthcare policies and procedures through continuing education methods. Most healthcare 
providers are aware of the risks and benefits of breastfeeding with OUD, but there is still an 
opportunity to ensure all staff have been exposed to the most current guidelines through annual 
education modules and/or station check-offs. Lastly, extending this research to diverse 




Knowledge gained from a more urban area and with diverse populations would provide unique 




This study builds understanding of the Recovery-Relapse Cycle, breastfeeding decision 
empowerment (Breastworks), and Newborn Well-Being. This study also confirms that 
responsible prescribing for symptom management that includes SUD screening and opioid risk 
assessment may help prevent women from entering the recovery-relapse cycle.  Continual 
empowerment is necessary to offset family instability, risk-prone neighborhoods, medication 
access issues, misperceived good intentions, and lac of healthcare provider sensitivity that 
women with OUD frequently perceive as stigma. The Breastfeeding Decision-Making in an 
Addiction Trajectory model can be used beginning with preconception and continuing 
throughout prenatal care into postpartum to address the various factors that may contribute to 





CHAPTER 5: “ALWAYS THERE”: SUPPORTING BREASTFEEDING AMONG 




Objective: To explore perceptions of support persons of women with opioid use disorder (OUD) 
that influence the women’s breastfeeding decision-making. 
Methods: A grounded theory study was conducted with women in treatment for OUD who 
breastfed their child in the last three years, and their support persons. Women were recruited 
from a drug rehabilitation therapy agency, a high-risk obstetrical office, and a major medical 
center serving this population. Support persons were identified by the women for participation in 
separate in-depth interviews. Memos and field notes were documented. Data were coded in three 
iterative and progressive phases: initial, focused, and theoretical, for the creation of a preliminary 
theoretical model called Breastfeeding Decision-Making in an Addiction Trajectory.   
Results: Data from five women and six support persons was analyzed using a dyad profile. One 
support person in a dyad participated without the index woman because of legal custody 
involvement that occurred during the study period. Findings indicated that support persons for 
women with OUD experienced uncertainty about breastfeeding related to potential maternal 
relapse and infant outcomes. Despite uncertainty, support persons offered physical and emotional 
breastfeeding support.   
Conclusions: Findings contributed to development of unique theoretical concepts within the 
Breastfeeding Decision-Making in an Addiction Trajectory Model. Support person uncertainty 
can be perceived as stigma by women with OUD which inadvertently disempowers the women 






There is a disparity in breastfeeding among women with opioid use disorder (OUD) that 
affects infant health outcomes (Schiff et al., 2018). Infants exposed to opioids in utero may 
experience severe gastrointestinal, nervous system, and respiratory symptoms, known as 
neonatal abstinence syndrome (NAS), that can be fatal if not properly managed (Kocherlakota, 
2014; McGlothen, Cleveland, & Gill, 2018). Breastfeeding has been identified as a method of 
alleviating NAS, potentially preventing the need for pharmacological treatment (Schiff et al., 
2018). Breastmilk protects the gastrointestinal tract in newborns and the skin-to skin contact that 
occurs during breastfeeding helps stabilize neurological symptoms of NAS (Klaman et al., 
2017). Furthermore, women with OUD who breastfeed learn their infant’s stress cues and build 
their confidence in caring for their infants quicker than their non-breastfeeding counterparts 
(Kocherlakota, 2014). Yet in 2016 only 56% of women with OUD initiated breastfeeding, 
compared to 81.1% of women among the general population (Centers for Disease Control and 
Prevention, [CDC], 2016; Schiff et al., 2018).  
There are many speculations as to why women with OUD do not breastfeed. Several 
investigators have found that women with OUD have fewer social supports and thus, less 
breastfeeding support (Demirci, Bogen, & Klionsky, 2015; Stone, 2015). Yet, the general 
literature on breastfeeding suggests that maternal breastfeeding support by family and friends is 
necessary for successful breastfeeding (Busch, Logan, & Wilkinson, 2014). Breastfeeding among 
women with OUD is critical to the health outcomes of infants, and adequate support from their 
family and friends is necessary to breastfeeding success (Welle-Strand et al., 2013). Therefore, 
the purpose of this study was to explore perceptions of breastfeeding among support persons that 






A grounded theory study was conducted using in-depth interviews with women in 
treatment for OUD and their identified support persons. This study is based on a phenomenon 
not previously described: how perceived stigma influenced breastfeeding decisions among 
women with OUD (Charmaz, 2006). Data were coded in three progressive, yet iterative phases: 
initial, focused, and theoretical coding, as described by Charmaz (2006). Participants’ voices 
were foregrounded through the initial coding phase and were the basis for focused and 
theoretical coding. The themes, categories, and subcategories were then organized into a 
theoretical framework referred to as Breastfeeding Decision-Making in an Addiction Trajectory 
(Appendix H). Data collected from support persons informed the study, and this data is reported 
in this paper. Agency and university IRB approvals were obtained (Appendix A). 
Setting and Sample 
 
The GT study took place in eastern North Carolina (eNC). Women were recruited from 
three separate sites: two locations within an outpatient drug rehabilitation therapy (DRT) agency, 
a high-risk obstetrical office, and a major medical center.  During recruitment efforts, the 
principal investigator (KC) clarified that breastfeeding included any amount of breastfeeding. 
Support persons were identified by the women being treated for OUD and were invited to 
participate in the study.  
Eligibility criteria for participants in the parent study were that the women spoke English, 
were between 18 and 54 years of age, were enrolled in a DRT agency in eNC for OUD, and 
breastfed their child within the last three years. Women were asked to identify a support person 
that could also be interviewed. The only support person inclusion criteria were identification by 






 Women were recruited face-to-face using flyers (Appendices I & J), whereas support 
persons were invited by the recruited women.  Support persons contacted the principal 
investigator to schedule an interview. A waiver of signed informed consent (Appendix B) was 
acquired to protect the women with OUD because a consent form would be “the only record 
linking the subject and the research … [meaning] the principal risk would be potential harm 
resulting from a breach of confidentiality” (Electronic Code of Federal Records, 2018, §46.117, 
section 2i). In contrast, support persons were required to sign an informed consent to participate 
(Appendix C). Prior to interviews, a demographic profile was obtained from all participants 
(Appendices E & G). The in-depth semi-structured interviews were conducted at a location of 
the participant’s choice. Interview questions included their personal thoughts of breastfeeding 
with OUD, perceptions of experiences with breastfeeding, and perceptions of assistance with 
breastfeeding (Appendices D & F). The interviews were audio-recorded for transcription and 
accuracy verification.  
Data Management and Analysis 
 
Pseudonyms were assigned to participants during transcription for participant protection. 
Transcripts and audio files were saved on a password protected and encrypted university hard 
drive. Audio recordings were deleted after the first author read transcripts a second time. The 
second author (KLL) verified transcription accuracy. Field notes were written immediately after 
each interview.  
Coding of support person data followed the same process as coding of data from the 
index women. Data were initially coded line-by-line, then grouped into more abstract categories 




person data to inform the developed theory of Breastfeeding Decision-Making in an Addiction 
Trajectory Model that was identified in chapter four (Appendix H). This theory posits that 
symptom management and social and environmental risk factors contribute to one of two 
pathways into addiction, pain-prescription or street drug, before entering a recovery-relapse 
cycle. This cycle then influences a woman’s ability to defend her breastfeeding decision based 
on her knowledge and perceptions of stigma from others through good intentions and healthcare 
provider sensitivity, thereby influencing newborn well-being. Support persons provided valuable 
information about perceptions of breastfeeding among women with OUD and the support that 
women received, which prompted further probe questions with each additional interview. Dyad 
profiles were developed and reviewed for similarities and relationships, which contributed to the 
development of the subtheme Breastworks (Appendix H).  
Results 
 
Five out of a total of ten women with OUD and their six support persons were included in 
the analysis (Table 4). One support person was interviewed prior to the dyad participant’s 
scheduled interview, which subsequently did not occur because of a child custody issue that 
occurred during the study period. Both White and African American women were invited to 
participate. However, no African American women participated because either their children 
were older than three, they did not breastfeed, or they declined to participate in the research. Ten 
to fifteen minutes was spent in general conversation about the health of the infants to build 
rapport prior to interviews. There were a total of 11 interviews, five with women who had 
support person participation and six with the support persons, totaling more than 3 hours, 94 





Table 4.  
Demographic Characteristics of Women with OUD and Their Support Persons (N = 11) 
 Characteristic Mean Range n (%) 
Women with OUD Age (years) 29.4 26-34 5 (100) 
 Race/Ethnicity 





 Education Level 
   Some HS 
   HS/GED 









   Unemployed 
   Full-Time 




   1 
   2 
   6 




Support Persons  Age (years) 38.7 29-57 6 (100) 
 Race/Ethnicity 
   Caucasian 
   
6 (100) 
 Education Level 
   Some College 




   Unemployed 
   Full-Time 







Support person uncertainty informed all three categories of the subtheme Breastworks 
(Appendix H) but focused mainly on Good Intentions. Breastworks came from a search of 
military terms after a discussion with a colleague for a pilot study (Cook & Larson, 2019). The 
military definition of Breastworks was a chest-height man-made wall used for protection of 
soldiers against enemy fire. In both the pilot and this study, Breastworks depicts the unrelenting 
fight these women face daily in defense of their decision to breastfeed, which in turn protects 
their infants. There was a recognized uncertainty among support persons about whether 
breastfeeding with OUD was a good decision, with four out of six support persons expressing 
uncertainty (Table 5). Yet, participants described their knowledge of the risks and benefits of 
breastfeeding from experiences with previous children, conversations with healthcare providers, 
and finding information for themselves on the internet. Uncertainty from support persons 
contributed to the uncertainty of the women through support persons’ good intentions. Three of 
the five women expressed uncertainty related to conversations held with support persons, family, 
and friends. Uncertainty was related to potential relapse risk and effects on infant health. One 
support person voiced uncertainty about breastfeeding with OUD, but believed that it is the best 
alternative for their situation: 
… it’s hard to say. I know I’ve worried about it some too, wondering if it was good for 
her or bad for her. I feel like that, when she [baby] was, ya know, still inside of her, she 
was kinda getting the same things as the breastmilk’s gone give her, ya know. So, I’m 
trying to-, I feel like it’s the best thing for us to do (Adam, 29-year-old, Hannah’s fiance). 
From prior discussion with her fiancé, one woman said, “I mean, I feel like it’s a good 





This is only one example of uncertainty expressed by a dyad. One woman perceived 
breastfeeding with OUD positively and felt strongly about it, though her support person 
(husband) was uncertain: 
I was really wanting to do the breastfeeding this time, so I’ve done a lot of research and 
done a lot of things I needed to do in order, so that we could still do this (Marie, 28-year-
old). 
One support person felt that breastfeeding with OUD was beneficial. She stated, “Uh, if 
they are clean I think it’s great because I think breastfeeding is the best thing for a child.” (Gerry, 
the 57-year-old mother of a woman who could not participate in an interview due to a child 
custody issue). One other support person echoed this positive outlook on breastfeeding among 
women with OUD.  
In contrast, one index woman explained that breastfeeding with OUD was detrimental to 
infant health, regardless of being in treatment or using street drugs: 
Oh no, no, no! There’s no, there’s no difference. Not when it comes to when you’re 
breastfeeding. It doesn’t make it any different that you’re in treatment for it. It’s still 
there. … Like, if you’re meaning, like, you’re saying, okay. You got two people using, 
but since this one’s getting help and going to treatment for it, it’s okay for her to 
breastfeed. … No. … I don’t. Because the drugs, it’s still there. … You can’t take the 






Women with OUD- Support Person Dyad Description (N = 11) 
   Perception of Breastfeeding with 
OUD 
Dyad Relationship Estimated Time 
Together (years) 
IP SP 
Hannah & Adam Fiancé 3 U U 
Marie & 
Linwood 
Spouse 10 P U 
Christina & 
Gabe 
Spouse 16 U P 
Tara & Lincoln Fiancé 3 N U 
Ashton & 
Carson 
Spouse 2 U U 
Gerry Mother 30 - P 
Footnotes: Pseudonyms used. IP: Index Participant/Women, SP: Support Person, U: Uncertain, 
P: Positive Perception, N: Negative Perception 
Most dyads ultimately agreed that breastfeeding with OUD in treatment was better than 
breastfeeding while using street drugs based on education they had received, either 
independently or from healthcare providers. One woman stated, “Just talking with the doctors 
and staff…. [they told me] that it’s more healthy for the baby. … [buprenorphine will] be in my 
breastmilk” (Christina, 34-year-old). Christina’s husband Gabe talked about his trust in the 
breastfeeding information that doctors had given them, making him comfortable with the 
decision to breastfeed. Another woman explained that she searched the internet to find answers: 
… from the research I had done, it seemed like there were benefits, umm, benefits of still 
breastfeeding, ya know. And also, the fact that according to what kind of medication 
you’re on, umm, some of it can be passed through the breast milk, but not enough for it to 
have an effect on the baby. So, still the benefits of breastfeeding would outweigh the 




Ashton’s husband, Carson, discussed his comfort with their daughter being breastfed in 
retrospect because he can now look back and see that it helped protect the infant.  
Even though most participants were uncertain of the benefits, the support persons 
maintained their support of the women in their decisions. Support persons expressed their 
support of women through both physical and emotional ways. For example, one support person 
spoke of physically supporting his wife in pumping for their newborn that remained in the 
hospital, “Well, I try to help her … just change the bottles out, whatever kind of help [she needs], 
kind of [a] running person that ‘go get’ what [she] needs” (Gabe, Christina’s husband, 37-year-
old). Another support person explained his emotional support for his fiancé, who had previously 
endured physical and emotional abuse from her ex-husband, during her breastfeeding: 
And she tried, ya know. And then when he was kind of rejecting, ya know, or whatever, 
and I’m like, ‘no, it’s not you’. You know what I mean. ‘This is a preemie baby, he don’t 
know’ (Lincoln, Tara’s fiancé, 38-year-old). 
Support persons felt that they were as supportive as they could possibly be at the time, 
but some offered potential improvements in their support in retrospect. One support person 
stated, “I mean the only [way I could be more supportive] maybe would be try to be more 
informed the last time, but ya know, normally you typically tend to listen to doctors” (Linwood, 
Marie’s husband, 35-year-old).  Two participants felt they needed to be at home to help more but 
had to be at work to make ends meet. This was best described when one support person that 
stayed home from his small business for a month stated, “Umm, the only time that I can 
remember maybe possibly being more helpful was if I could’ve afforded uh to stay away from 




No matter the amount of uncertainty, one participant summed up the overall stance of 
support persons when he stated, “Uh, just back their play. … Don’t never give them a reason to 
doubt. Ya know what I mean. Support their decision and it shows you support their decision” 
(Lincoln, Tara’s fiancé, 38-year-old).  
Discussion 
 
 This analysis of dyad data from a Grounded Theory study of women in treatment for 
OUD aimed to explore how perceptions of support persons influence women’s decisions to 
breastfeed. This was an educated sample that trusted health care providers and received critically 
important information that they valued. The findings may provide foundational knowledge for 
healthcare professionals working with women with OUD and their support persons, serving as a 
step toward identifying new methods of breastfeeding promotion in this population. This study 
provided the perspectives of a small sample of White women and their support persons in a 
single geographic location, whose perspectives are critical to understanding breastfeeding 
decision-making in an addiction trajectory. This homogenous sample is likely due to African 
Americans experiencing more stigma and having less trust in the research community secondary 
to historical events. 
 While literature suggests that social support networks are minimal for women with OUD, 
all of the women from this study had a support person to participate (Demirci et al., 2015). A 
person that expressed uncertainty might be considered unsupportive, yet these individuals were 
perceived as being highly supportive of breastfeeding by the women participating. When looking 
at the Breastfeeding Decision-Making in an Addiction Trajectory Model (Appendix H), support 
person uncertainty is expressed through Good Intentions, while medical staff uncertainty is 




often perceived by women as stigma, or societal judgement against breastfeeding, which can 
undermine the effects of Breastworks.  
There are research and practice implications from this study. First, development of a 
mobile application for breastfeeding education to reach women with OUD and their support 
persons, that can be accessed on demand, with critical benefits. One support person suggested 
that mobile applications are the best way to reach anyone in today’s technologically inclined 
society. Additionally, numerous mobile applications have been developed and effectively 
implemented among other high-risk populations, such as those with alcoholism or suicidal 
tendencies (Han & Lee, 2018). Second, women with OUD who are successful in their recovery 
could function as community health workers, liaisons between the women, their support persons, 
and traditional healthcare professionals. The community health worker’s primary role would be 
to enroll women in services available and suggest evidence-based resources for the women to 
make educated decisions independently (Hodgins, Lang, Malseptic, Melby, & Connolly, 2019; 
Morgan, Lee, and Sebar, 2015). Lastly, extending this research to diverse populations and 
geographic locations would broaden the scope of the current theoretical model. Knowledge 
gained from a more urban area and with diverse populations would provide additional 




These findings contribute to the unique theoretical concepts of Breastfeeding Decision-
Making in an Addiction Trajectory model. Support persons described uncertainty that may enter 
the model as Good Intentions, which can be perceived as stigma by women with OUD. Such 




thereby negatively impacting newborn well-being.  Breastworks could be strengthened through 
use of a mobile application and implementation of community health workers that provide 
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Informed Consent to Participate in Research 
Information to consider before taking part in research that has no 
more than minimal risk. 
 
Title of Research Study: Understanding Stigma of Breastfeeding Among Women with Substance Use 
Disorder  
 
Principal Investigator: Kristy Cook, Principal Investigator (Person in Charge of this Study) 
Institution, Department or Division: East Carolina University, College of Nursing 
Address: Health Sciences Building, East Carolina University 
Telephone #: 252-717-3629 
 
 
Researchers at East Carolina University (ECU), PORT Human Services, and Vidant Medical Center study 
issues related to society and health problems.  To do this, we need the help of volunteers who are willing 
to take part in research. 
Why am I being invited to take part in this research? 
The purpose of this research is to understand how stigma influences breastfeeding decisions among 
women with substance use disorder (SUD). You are being invited to take part in this research because you 
are a woman between 18 and 54 years old, enrolled in a treatment program, and have recent breastfeeding 
experience within the last three years. The decision to take part in this research is yours to make.  By 
doing this research, I hope to learn how you perceive stigma related to breastfeeding, how stigma 
influenced your breastfeeding decisions, how a support person that you identify perceives stigma related 
to breastfeeding, and how local and national guidelines contribute to your breastfeeding decisions.   
If you volunteer to take part in this research, you will be one of about 30 people to do so.   
Are there reasons I should not take part in this research?  
I understand I should not volunteer for this study if: 
 I am under 18 years of age or over 54 years of age 
 I do not speak English 
 I am not enrolled in a drug treatment program 
 I do not have a child that I have tried to breastfeed in the last three years 
 I cannot sit for at least one hour 
  
What other choices do I have if I do not take part in this research? 
You can choose not to participate.   
 
Where is the research going to take place and how long will it last? 
The research will be conducted at a private location that we agree on, which may include an office in the 
location you agree to participate from, your home, or another location. You will need to come to the 




volunteer for this study is 4 hours over the next year (2 hours maximum per interview, if second interview 
is needed).   
 
What will I be asked to do? 
You will be asked to do the following: 
 Answer questions about your experience with breastfeeding your child and what influenced your 
decisions about breastfeeding 
 Identify a support person and either get permission for me to contact them or take them a flyer 
inviting them to contact me to participate 
 Allow me to audio-record our conversation so that I can transcribe (type) it, have one of my 
research mentors review it, and then immediately delete the recording 
 
What might I experience if I take part in the research? 
I don’t know of any risks (the chance of harm) associated with this research.  Any risks that may occur 
with this research are no more than what you would experience in everyday life.  I don't know if you will 
benefit from taking part in this study. There may not be any personal benefit to you, but the information 
gained by doing this research may help others in the future. 
 
Will I be paid for taking part in this research? 
I will be able to pay you for the time you volunteer while being in this study.  A $20 gift card will be 
provided for each interview completed. Since the total of the gift cards will be less than $600 you will not 
receive an IRS 1099 form.   
  
Will it cost me to take part in this research?  
 It will not cost you any money to be part of the research. 
 
Who will know that I took part in this research and learn personal information about me? 
ECU and the people and organizations listed below may know that you took part in this research and may 
see information about you that is normally kept private.  With your permission, these people may use your 
private information to do this research: 
 Any agency of the federal, state, or local government that regulates human research.  This includes 
the Department of Health and Human Services (DHHS), the North Carolina Department of Health, 
and the Office for Human Research Protections. 
 The University & Medical Center Institutional Review Board (UMCIRB) and its staff have 
responsibility for overseeing your welfare during this research and may need to see research records 
that identify you. 
 People designated by Vidant Medical Center and Vidant Health, East Carolina University Women’s 
Physicians, and PORT Human Services 
 If you are a patient at ECU or Vidant, a copy of this form will be placed in your medical records.   
 
How will you keep the information you collect about me secure?  How long will you keep 
it? 
 Your name and contact information will be kept on an encrypted research drive through East 
Carolina University. This file will be kept separate from other study data and will be deleted at 
the end of the study duration. 
 Audio-recordings of the interviews will also be kept on an encrypted research drive through East 
Carolina University. These files will be deleted immediately after they are transcribed and 




 Electronic copies of the transcripts will be kept on an encrypted research drive through East 
Carolina University and hard copies will be filed in a locked cabinet of a locked office within 
ECU College of Nursing. All of these files de-identified files may be used for presentations on 
the study but will be deleted and destroyed after at least three years.  
 
What if I decide I don’t want to continue in this research? 
You can stop at any time after it has already started. There will be no consequences if you stop and you 
will not be criticized.  You will not lose any benefits that you normally receive.  
Who should I contact if I have questions? 
The people conducting this study will be able to answer any questions concerning this research, now or in 
the future.  You may contact the Principal Investigator at 252-717-3629 (days, between 9 am and 9 pm).    
If you have questions about your rights as someone taking part in research, you may call the Office of 
Research Integrity & Compliance (ORIC) at phone number 252-744-2914 (days, 8:00 am-5:00 pm). You 
may also call the Vidant Health Center for Research and Grants at 252-847-1177. If you would like to 
report a complaint or concern about this research study, you may call the Director of the ORIC, at 252-
744-1971 and the Vidant Health Risk Management Office at 252-413-4473. 
 
Is there anything else I should know? 
Most people outside the research team will not see your name or your research record. However, one 
exception is information about child abuse or neglect and harm to yourself or others. 
  
I have decided I want to take part in this research.  What should I do now? 
The person obtaining informed consent will ask you to read the following and if you agree, you should 
verbally express agreement:   
 
 I have read (or had read to me) all of the above information.   
 I have had an opportunity to ask questions about things in this research I did not understand and 
have received satisfactory answers.   
 I know that I can stop taking part in this study at any time.   
 By verbally agreeing to this informed consent form, I am not giving up any of my rights.   
 I have been given a copy of this consent document, and it is mine to keep.  
 
 
Person Obtaining Informed Consent:  I have conducted the initial informed consent process.  I have 
orally reviewed the contents of the consent document with the person who has verbally agreed with the 
above and answered all of the person’s questions about the research. 
 
             











Informed Consent to Participate in Research 
Information to consider before taking part in research that has no 
more than minimal risk. 
 
Title of Research Study: Understanding Stigma of Breastfeeding Among Women with Substance Use 
Disorder  
 
Principal Investigator: Kristy Cook, Principal Investigator (Person in Charge of this Study) 
Institution, Department or Division: East Carolina University, College of Nursing 
Address: Health Sciences Building, East Carolina University 
Telephone #: 252-717-3629 
 
 
Researchers at East Carolina University (ECU), PORT Human Services, and Vidant Medical Center study 
issues related to society and health problems.  To do this, we need the help of volunteers who are willing 
to take part in research. 
Why am I being invited to take part in this research? 
The purpose of this research is to understand how stigma influences breastfeeding decisions among 
women with substance use disorder (SUD). You are being invited to take part in this research because you 
have been identified, by a previous participant, as someone that is supportive of that person. The decision 
to take part in this research is yours to make. By doing this research, I hope to learn how women with 
SUD perceive stigma related to breastfeeding, how stigma influences breastfeeding decisions among 
women with SUD, how you perceive stigma related to breastfeeding, and how local and national 
guidelines contribute to such breastfeeding decisions.   
 
If you volunteer to take part in this research, you will be one of about 30 people to do so.   
Are there reasons I should not take part in this research?  
I understand I should not volunteer for this study if: 
 I am not a support person of a woman with SUD 
 I do not speak English 
 I cannot sit for at least one hour 
  
What other choices do I have if I do not take part in this research? 
You can choose not to participate.   
 
Where is the research going to take place and how long will it last? 
The research will be conducted at a private location that we agree on, which may include an office, your 
home, or another location. You will need to come to the identified location 1-2 times during the study. 
The maximum amount of time you will be asked to volunteer for this study is 4 hours over the next year 





What will I be asked to do? 
You will be asked to do the following: 
 Answer questions about your perceptions of stigma related to breastfeeding among women with 
SUD 
 Allow me to audio-record our conversation so that I can transcribe (type) it, have one of my 
research mentors review it, and then immediately delete the recording 
 
What might I experience if I take part in the research? 
I don’t know of any risks (the chance of harm) associated with this research.  Any risks that may occur 
with this research are no more than what you would experience in everyday life.  I don't know if you will 
benefit from taking part in this study. There may not be any personal benefit to you, but the information 
gained by doing this research may help others in the future. 
 
Will I be paid for taking part in this research? 
I will be able to pay you for the time you volunteer while being in this study.  A $20 gift card will be 
provided for each interview completed. Since the total of the gift cards will be less than $600 you will not 
receive an IRS 1099 form.   
  
Will it cost me to take part in this research?  
 It will not cost you any money to be part of the research. 
 
Who will know that I took part in this research and learn personal information about me? 
ECU and the people and organizations listed below may know that you took part in this research and may 
see information about you that is normally kept private.  With your permission, these people may use 
your private information to do this research: 
 Any agency of the federal, state, or local government that regulates human research.  This includes 
the Department of Health and Human Services (DHHS), the North Carolina Department of Health, 
and the Office for Human Research Protections. 
 The University & Medical Center Institutional Review Board (UMCIRB) and its staff have 
responsibility for overseeing your welfare during this research and may need to see research records 
that identify you. 
 
How will you keep the information you collect about me secure?  How long will you keep 
it? 
 Your name and contact information will be kept on an encrypted research drive through East 
Carolina University. This file will be kept separate from other study data and will be deleted at 
the end of the study duration. 
 Audio-recordings of the interviews will also be kept on an encrypted research drive through East 
Carolina University. These files will be deleted immediately after they are transcribed and 
verified by a research mentor. 
 Electronic copies of the transcripts will be kept on an encrypted research drive through East 
Carolina University and hard copies will be filed in a locked cabinet of a locked office within 
ECU College of Nursing. All of these files de-identified files may be used for presentations on 





What if I decide I don’t want to continue in this research? 
You can stop at any time after it has already started. There will be no consequences if you stop and you 
will not be criticized.  You will not lose any benefits that you normally receive.  
 
Who should I contact if I have questions? 
The people conducting this study will be able to answer any questions concerning this research, now or in 
the future.  You may contact the Principal Investigator at 252-717-3629 (days, between 9 am and 9 pm).    
If you have questions about your rights as someone taking part in research, you may call the Office of 
Research Integrity & Compliance (ORIC) at phone number 252-744-2914 (days, 8:00 am-5:00 pm). If 
you would like to report a complaint or concern about this research study, you may call the Director of the 
ORIC, at 252-744-1971. 
 
Is there anything else I should know? 
Most people outside the research team will not see your name or your research record. However, one 
exception is information about child abuse or neglect and harm to yourself or others. 
  
I have decided I want to take part in this research.  What should I do now? 
The person obtaining informed consent will ask you to read the following and if you agree, you should 
sign this form:   
 
 I have read (or had read to me) all of the above information.   
 I have had an opportunity to ask questions about things in this research I did not understand and 
have received satisfactory answers.   
 I know that I can stop taking part in this study at any time.   
 By signing this informed consent form, I am not giving up any of my rights.   
 I have been given a copy of this consent document, and it is mine to keep.  
 
          _____________ 




Person Obtaining Informed Consent:  I have conducted the initial informed consent process.  I have 
orally reviewed the contents of the consent document with the person who has verbally agreed with the 
above and answered all of the person’s questions about the research. 
 
             





APPENDIX D: SEMI-STRUCTURED INTERVIEW GUIDE FOR WOMEN 
 
After verbal informed consent is obtained. 
1. Tell me a little about your family. 
a. Probes: How many children do you have? How old are they?  
2. Please tell me about your experience breastfeeding your child(ren).  
3. How did you decide to breastfeed? 
a. Probe: Was there something or someone that influenced your decision?  
b. [If not breastfeeding any longer] Please describe the events that led up to your 
decision to stop breastfeeding? 
4. What do you think about breastfeeding with opioid use disorder? 
5. Could you describe resources that were available to you that helped you with 
breastfeeding? 
a. Probes: Lactation Consultants? Educational sessions? Where? When? Self-
education through brochures/pamphlets/internet? 
6. Could you describe anyone in particular that assisted you to breastfeed? 
a. Please give me an example of a good experience you had with someone.  
i. Probes: Who, What, When, Where? 
7. Could you describe someone/something that made it more difficult to breastfeed? 
a. Please give me an example of a bad experience you had with someone. 
i. Probes: Who, What, When, Where? 




a. Probes: [If infant was separated from mother for procedures, etc.] How long was 
your baby away from you for [procedure identified]? How did the absence of your 
infant influence your decisions regarding breastfeeding? Or did it at all? 




























APPENDIX F: INTERVIEW GUIDE FOR SUPPORT PERSONS 
 
Begin after signed informed consent is obtained. 
1. How do you know the person that referred you for this study? 
2. What do you think about breastfeeding among women with opioid use disorder? 
3. In what ways do you feel that women with OUD are assisted in their decision to 
breastfeed? 
4. In what ways do you feel that women with OUD have difficulty in their decision to 
breastfeed? 
5. Please give me an example of how you have been helpful of [name] when it came to 
breastfeeding. 
6. Please give me an example of a time that you felt you could have been more helpful 
when it came to breastfeeding.  
7. Can you tell me what you have seen about the assistance others have offered her for 
breastfeeding? 
a. Probes: Who, What, When, Where? 







































APPENDIX J: INVITATIONAL FLYER FOR SUPPORT PERSONS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
